








wnThe copyright of this thesis vests in the author. No
quotation from it or information derived from it is to be
published without full acknowledgement of the source.
The thesis is to be used for private study or non-
commercial research purposes only.
Published by the University of Cape Town (UCT) in terms










THE PHYSIOLOGICAL EFFECTS OF HEART RATE 
VARIABILITY BIOFEEDBACK DURING LABORATORY 
INDUCED COGNITIVE STRESS 
By 
Gabriell Elizabeth Prinsloo 
This thesis is presented for the degree of
DOCTOR OF PHILOSOPHY
In the Department of Human Biology
Faculty of Health Sciences
University of Cape Town
South Africa
10 December 2012
UCT/MRC Research Unit for Exercise Science and Sports Medicine 
Sports Science Institute of South Africa 













TABLE OF CONTENTS 
Table of contents .................................................................................................................................... ii 
List of figures ......................................................................................................................................... vi 
List of tables......................................................................................................................................... viii 
Declaration ............................................................................................................................................ ix 
Acknowledgements ................................................................................................................................ x 
List of abbreviations ............................................................................................................................. xii 
List of publications and presentations ................................................................................................xiv
Abstract ................................................................................................................................................ xv
Chapter 1 – Literature review: prior research and clinical applications ..............................................1
1.1 Introduction and scope of thesis ..................................................................................................1
1.2 Psychosocial stress........................................................................................................................3
1.2.1 Physiology of the stress response..........................................................................................4
1.2.2 The effect of stress on disease...............................................................................................5
1.2.3 The effect of stress on cognition and performance...............................................................7
1.2.4 Stress management ...............................................................................................................8
1.3 Heart Rate Variability..................................................................................................................10
1.3.1 Measurement of HRV...........................................................................................................10
1.3.2 Control of heart rate, blood pressure and respiration ........................................................ 12 
1.3.3 Control of HRV ..................................................................................................................... 14 
1.3.4 Modulators of HRV in health ............................................................................................... 17 
1.3.5 Changes in HRV during stress and relaxation ...................................................................... 19 
1.3.6 Changes in HRV in disease ................................................................................................... 20 
1.3.7 The relationship between HRV and cognitive performance ................................................ 23 
1.3.8 HRV biofeedback .................................................................................................................. 23 














1.4.1 Interpretation of different frequency bands ....................................................................... 27 
1.4.2 Impact of age and sex on EEG .............................................................................................. 29 
1.4.3 Effect of anxiety and relaxation on EEG ............................................................................... 29 
1.4.4 Effect of HRV biofeedback and meditation on EEG ............................................................. 30 
1.5 Summary and conclusion ............................................................................................................ 32 
1.6 Objectives of the thesis ............................................................................................................... 34 
Chapter 2 – Methodology .................................................................................................................... 35 
2.1 Participants ................................................................................................................................. 35 
2.2 Training and familiarization protocol .......................................................................................... 36 
2.3 Experimental trial ........................................................................................................................ 38 
2.3.1 Modified Stroop Task ........................................................................................................... 39 
2.3.2 Questionnaires used ............................................................................................................ 40 
2.3.3 Data recording ..................................................................................................................... 41 
2.4 Statistical analysis ....................................................................................................................... 43 
2.4.1 Subject characteristics ......................................................................................................... 43 
2.4.2 Cognitive performance ........................................................................................................ 43 
2.4.3 HRV and respiratory data ..................................................................................................... 43 
2.4.4 EEG ....................................................................................................................................... 44 
2.4.5 Questionnaires ..................................................................................................................... 44 
2.4.6 General ................................................................................................................................. 45 
Chapter 3 – The effect of a single session of short duration HRV biofeedback on cognitive 
performance during laboratory induced cognitive stress................................................................... 46 
3.1 Introduction ................................................................................................................................ 46 
3.2 Methods ...................................................................................................................................... 47 
3.3 Results ......................................................................................................................................... 47 
3.3.1 Subject characteristics ......................................................................................................... 47 
3.3.2 Cognitive performance ........................................................................................................ 47 














3.5 Conclusion ................................................................................................................................... 54 
Chapter 4 – The effect of a single session of HRV biofeedback on measures of HRV during 
laboratory induced cognitive stress .................................................................................................... 55 
4.1 Introduction ................................................................................................................................ 55 
4.2 Methods ...................................................................................................................................... 56 
4.3 Results and Discussion ................................................................................................................ 56 
4.3.1 Normal response to stress ................................................................................................... 56 
4.3.2 Effects of intervention ......................................................................................................... 61 
4.3.3 Rest after intervention ......................................................................................................... 61 
4.3.4 Response to cognitive stress after the intervention ............................................................ 62 
4.4 Conclusion ................................................................................................................................... 64 
Chapter 5 – The effect of a single session of short duration HRV biofeedback on EEG .................... 65 
5.1 Introduction ................................................................................................................................ 65 
5.2 Methods ...................................................................................................................................... 66 
5.3 Results ......................................................................................................................................... 66 
5.3.1 BIO intervention scores ........................................................................................................ 66 
5.3.2 EEG measures....................................................................................................................... 66 
5.4 Discussion .................................................................................................................................... 72 
5.4.1 EEG changes during the intervention .................................................................................. 72 
5.4.2 EEG changes in the immediate post intervention period .................................................... 74 
5.5 Conclusion ................................................................................................................................... 75 
Chapter 6 – The effect of a single session of short duration HRV biofeedback on measures of 
anxiety and relaxation states ............................................................................................................... 76 
6.1 Introduction ................................................................................................................................ 76 
6.2 Methods ...................................................................................................................................... 78 
6.3 Results ......................................................................................................................................... 78 
6.3.1 STAIT and STAIS .................................................................................................................... 78 














6.3.3 Scores for helpfulness and sleepiness ................................................................................. 79 
6.4 Discussion .................................................................................................................................... 82 
6.5 Conclusion ................................................................................................................................... 84 
Chapter 7 – Summary, clinical application and conclusions ............................................................... 85 
7.1 Overview and clinical interpretation .......................................................................................... 85 
7.1.1 Chapter 3 .............................................................................................................................. 85 
7.1.2 Chapter 4 .............................................................................................................................. 86 
7.1.3 Chapter 5 .............................................................................................................................. 88 
7.1.4 Chapter 6 .............................................................................................................................. 89 
7.2 Clinical application ...................................................................................................................... 92 
7.3 Limitations ................................................................................................................................... 94 
7.4 Future research ........................................................................................................................... 95 
References ............................................................................................................................................ 96 
Appendix A - Explanation of authorship for each publication ........................................................... 134 
Appendix B - Copyright clearance ...................................................................................................... 136 
Appendix C - Informed consent .......................................................................................................... 137 
Appendix D - Intake information ........................................................................................................ 138 
Appendix E - Questionnaires .............................................................................................................. 139 
















LIST OF FIGURES 
Figure 1.1 Schematic summary of the key factors regulating low and high frequency heart rate 
variability............................................................................................................................................... 15 
Figure 2.1 Diagram depicting the time line of the trial protocol on the day of final testing ................ 38 
Figure 3.1 The percentage of correct responses to squares cues (a), word cues (b) and total cues (c) 
during the first and second modified Stroop tasks in the BIO and COM groups .................................. 48 
Figure  3.2  Individual  subject’s  average  percentage  improvement  in  reaction  time to all colours during 
the first and second modified Stroop tasks in the BIO and COM groups ............................................. 50 
Figure   3.3   Individual   subject’s   average   percentage   improvement   in reaction time to grey colours 
during the first and second modified Stroop tasks in the BIO and COM groups .................................. 50 
Figure  3.4  Individual  subject’s  average  percentage  change in the standard deviation of their reaction 
time to all colours during the first and second modified Stroop tasks in the BIO and COM groups .... 51 
Figure 4.1 RMSSD during Rest 1 (R1) and Stroop 1 (S1) (before the intervention) and during Rest 2 
(R2) and Stroop 2 (S2) (after the intervention) in the BIO (n=9) and COM (n=9) groups ..................... 57 
Figure 4.2 TF power (a), HF power (b) and LF power (c) during Rest 1 (R1) and Stroop 1 (S1) (before 
the intervention) and during Rest 2 (R2) and Stroop 2 (S2) (after the intervention) in the BIO (n=9) 
and COM (n=9) groups .......................................................................................................................... 60 
Figure 5.1 Relative theta (a), alpha (b) and beta power (c) and theta/beta ratios (d) at Fz, Cz and Pz 
during the intervention in the BIO and COM groups (n = 8 in each in group at Fz and Cz, n = 7 in each 
group at Pz) ........................................................................................................................................... 67 
Figure 5.2 Absolute theta, alpha and beta power during Rest 1 and Rest 2 at Fz (a), Cz (b) and Pz (c) in 
the BIO and COM groups (n = 8 in each group at Fz and Cz, n = 7 in each group at Pz) ....................... 69 
Figure 5.3 Theta/beta ratios at Fz (a), Cz (b) and Pz (c) during Rest 1 and Rest 2 in the BIO and COM 














Figure 6.1 Scores for STAIS (a), SRSI3 Total Relaxation States (b), SRSI3 Mindfulness (c), SRSI3 
Energized Positive Feelings (d), SRSI3 Basic Relaxation (e) and SRSI3 Transcendence (f) before and 
after testing in the BIO (n=9) and COM (n=9) groups ........................................................................... 80 
Figure 7.1 Summary of the effects of a single episode of HRV biofeedback on HRV, EEG, cognitive 













LIST OF TABLES 
Table 1.1 Physical disease states that are associated with increased psychological stress ................... 6 
Table 1.2 Changes in measures of HRV associated with cardiovascular disease states, metabolic 
syndrome and chronic respiratory disease states ................................................................................ 22 
Table 4.1 Respiratory frequency, heart rate and heart rate variability measures throughout testing in 
the BIO (n = 9) and COM (n = 9) groups. Data are expressed as medians with interquartile ranges in 
brackets. ................................................................................................................................................ 58 
Table 5.1 Absolute power in theta, alpha and beta EEG bands at Fz, Cz and Pz during the intervention
in the BIO and COM groups (n = 8 in each group at Fz and Cz, n = 7 in each group at Pz). Data are
expressed as medians with interquartile ranges in brackets. ..............................................................66
Table 5.2 Relative power in theta, alpha and beta EEG bands at Fz, Cz and Pz during Rest 1 and Rest 2
in the BIO and COM groups (n = 8 in each group at Fz and Cz, n = 7 in each group at Pz)...................70
Table 6.1 Scores for each individual subcategory in the Smith Relaxation States Inventory 3 before















DOCTORAL DEGREES BOARD 
UNIVERSITY OF CAPE TOWN 
Student Administration Building,  
Private Bag X3, Rondebosch, 7701 
Tel: +27 21 650 2202    Fax:  +27 21 650 4913 
E-mail: janine.isaacs@uct.ac.za 
 
PhD Thesis title: The physiological effects of heart rate variability biofeedback during laboratory 





I           (full name) hereby: 
(a) Grant the University of Cape Town free licence to reproduce the above thesis in whole or in 
part, for the purpose of research; 
 
(b) Declare that: 
(i) The above thesis is my own unaided work, both in concept and 
execution, and that apart from the normal guidance from my 
supervisor, I have received no assistance. 
 
 
(ii) Neither the substance nor any part of the above thesis has been 
submitted in the past, or is being, or is to be submitted for a degree 
at this University or at any other University. 
 
 
I am now presenting the thesis for examination for the degree of PhD. 
 
 


















I would like to express my deepest gratitude and appreciation to all of the people below who have 
helped me to make my thesis what it is and, more importantly, who have helped me to become who 
I am over the last few years: 
 To Jane Prinsloo for providing endless loving support and encouragement in EVERYTHING 
that I want to do, in so many different ways. Mom for being one of my best friends. And for 
all of the time editing this thesis! Dad I wish that you could be here now. 
 
 To David Karpul for his endless support, encouragement and love, no matter how grumpy 
and stressed I was, despite being somewhat neglected. For the fun and laughter that kept 
me sane.  And for his always willing help with my work. He was right, it is easier and more 
fun to do things together  rather  than  on  one’s  own! 
 
 To Anna Prinsloo and all of my friends both at ESSM and elsewhere, for patiently and 
understandingly accepting being sidelined for my thesis in the last couple years, and for the 
fun interludes which are so important to me.   I’m   so   looking   forward   to   having   a   more  
balanced life and spending more time with all of you! Especially to Richard Hartley for all of 
our adventures, for morning beach walks and the feed the student scheme and for always 
being there should I need. 
 
 To my Officemates – the BEST I could possibly ask for! We had good conversation, hard 
work, respect and friendship – may it continue.  
 
 To Prof Wayne Derman for being a mentor and friend, so much more than a supervisor. He 
has given me support, guidance and encouragement in all areas of my life over the last few 
years. He has always made time, no matter how busy he was. For his humour, enthusiasm 
and fun approach to life, and for his outstanding skills in writing and teaching, I hope that I 
have absorbed some of this over the years.  
 
 To Dr Laurie Rauch for all the hard work and time that he put into all phases of my research. 














so patient, positive, supportive and kind despite all of my frustrated debating as I grappled 
with understanding the complex topic of HRV. 
 
 To Prof Mike Lambert for ALWAYS being there to answer my many questions and for 
patiently teaching me about statistics - without   his   help   this   thesis   wouldn’t   have   been  
possible. 
 
 To Prof Tim Noakes for being such an inspiring leader and for encouraging me to join ESSM 
at the very beginning. 
 
 To all of the stressed men who were so willing to give up their time to participate in my 
research. Without them there would be no study. 
 
 To Mrs Woolies for providing her organic 70 % dark chocolate and Mr Lindt for dark 
chocolate and Lindor balls. This was the stuff that fuelled the inspirations. 
 
 And last but not least, to all of the people who have been a part of my life over the last 7 
















LIST OF ABBREVIATIONS 
ACC Anterior cingulate cortex 
ACTH Adrenocorticotropic hormone 
ANOVA Analysis of variance 
AVP Arginine vasopressin 
BIO group Biofeedback intervention group 
BP Blood pressure 
BRS Baroreflex sensitivity 
CAD Coronary artery disease  
CIC Cardio inhibitory centre 
COM group Comparative intervention group 
COPD Chronic obstructive pulmonary disease 
CRH Corticotropin releasing hormone 
CVLM Caudal ventrolateral medulla 




FEV1 Forced expiratory volume in 1 second 
GIT Gastrointestinal tract 
GRs Glucocorticoid receptors 
HF High frequency 
HPA Hypothalamo-pituitary-adrenocortical 
HR Heart rate 
HRV Heart rate variability 
IBI Interbeat interval 
IQR Inter quartile range 
LC/NE Locus ceruleus/nor epinephrine 
LF Low frequency 
MBSR Mindfulness based stress reduction  
MI Myocardial infarction 
MRs Mineralocorticoid receptors 











NN50 Number of successive NN intervals having a difference greater than 50 ms
NTS Nucleus tractus solitarius
pNN50 Proportion of the total number of NN intervals
PVN Paraventricular hypothalamic nucleus
R1 First rest period
R2 Second rest period
REM Rapid eye movement
RF Respiratory frequency
RMSSD Root mean square of the successive differences of the RR intervals
RR interval Interval between peaks of the QRS complex
RSA Respiratory sinus arrythmia
RVLM Rostral ventrolateral medulla
S1 First Stroop task
S2 Second Stroop task
SBP Systolic blood pressure
SDANN Standard deviation of the average NN interval
SDNN Standard deviation of the normal to normal interval
SRSI3 Smith Relaxation State Inventory
STAIS Spielberger State Anxiety Inventory
STAIT Spielberger Trait Anxiety Inventory 
TF Total frequency
VAS Visual Analogue Scale
VF Ventricular fibrillation













LIST OF PUBLICATIONS AND PRESENTATIONS 
Publications 
The work described in this thesis has been published in or is in review with the following journals: 
1. Prinsloo GE, Rauch HGL, Lambert MI, Muench F, Noakes TD, Derman WE. The effect of short
duration heart rate variability (HRV) biofeedback on cognitive performance during
laboratory induced cognitive stress. Applied Cognitive Psychology 25: 792 – 801 (2011)
2. Prinsloo GE, Derman WE, Lambert MI, Rauch HGL. The effect of a single session of short
duration biofeedback-induced deep breathing on measures of heart rate variability during
laboratory induced cognitive stress: a pilot study. Applied Psychophysiology and Biofeedback
(in review, revisions requested)
3. Prinsloo GE, Rauch HGL, Karpul D, Derman WE. The effect of a single session of short
duration heart rate variability biofeedback on EEG: a pilot study. Applied Psychophysiology
and Biofeedback (accepted for publication)
4. Prinsloo GE, Derman WE, Lambert MI, Rauch HGL. The effect of a single episode of short 
duration heart rate variability biofeedback on measures of anxiety and relaxation states.
International Journal of Stress Management (in review, revisions requested)
Conference Presentations and Proceedings
1. October 2008: 3rd Clinical Sports Medicine Conference, Cape Town, South Africa. “The effect
of short duration heart rate variability (HRV) biofeedback on HRV and cognitive performance
during  laboratory  induced  cognitive  stress”.
2. October 2009: 13th Biennial International Conference of the South African Sports Medicine
Association,   Durban,   South   Africa.   “The   effect   of   short   duration   heart   rate   variability












Psychosocial stress is increasingly prevalent in the world today, and can lead to anxiety, impaired 
cognitive function and the development of both psychological and physical disorders. As a result, it is 
increasingly important to find effective stress management techniques that are easy to use. Heart 
rate variability (HRV) biofeedback is effective in reducing stress as well as managing chronic disease. 
It facilitates easy manipulation of HRV, and, therefore, potentially provides a valuable intervention 
for altering the activity of the autonomic nervous system. 
The aim of this thesis was to examine the effects of a single 10 minute episode of HRV biofeedback 
on measures of HRV and EEG during and immediately after the intervention, measures of HRV and
cognitive performance during laboratory induced cognitive stress and subjective feelings of anxiety
and relaxation states after testing.
Eighteen healthy male volunteers (34 ± 6 years) exposed to work-related stress, were randomised
into an HRV biofeedback intervention (BIO) and a comparative intervention group (COM). Subjects in
the BIO group used a hand-held mobile HRV biofeedback device, which measured the real-time
interbeat-interval (IBI) of the heart and displayed a wave reflecting respiratory sinus arrythmia (RSA).
Using the RSA wave, users are guided to find their optimal slow respiration rate. The COM group
used a device which appeared identical, but made use of a different algorithm to display a wave on
the screen. Subjects were informed that the wave represented their blood density and were
instructed to watch the wave whilst not thinking any stressful thoughts. They were not instructed to
alter the wave in any way.
All subjects underwent a single standardised training session during the week prior to the start of 
their experimental trials. The experimental trial consisted of 5 consecutive time periods: a 5 minute 
eyes-closed rest period (Rest 1), a modified Stroop task (Stroop 1), the 10 minute intervention 
period, a second 5 minute eyes-closed rest period (Rest 2) and a second modified Stroop task 
(Stroop 2). The modified Stroop task included having to mentally count 18 white squares randomly 
presented between colour words. Differences in reaction time responding to colour words as well as 
mistakes made in responding to cues between Stroop 1 and 2 were analysed. Respiratory rate and 
HRV were recorded throughout testing. Time-domain variables including mean heart rate (HR), 











bands and respiratory frequency (RF) were calculated. EEG was recorded during the intervention and 
during rest periods before and after the intervention. Power spectral density in theta, alpha and 
beta frequency bands and theta/beta ratios were calculated. The measurement of changes in HRV 
and EEG provides insight into the underlying physiological changes that occur during HRV 
biofeedback. The Spielberger Trait Anxiety Inventory (STAIT) was completed at recruitment, and the 
Spielberger State Anxiety Inventory (STAIS) and the Smith Relaxation States Inventory 3 (SRSI3) were 
completed before and after testing. Subjects rated the subjective efficacy of the intervention as well 
as feelings of sleepiness using a visual analogue scale (VAS) devised for this study. 
Changes in cognitive performance are described in Chapter 3. While both groups improved their
reaction times (p<0.01), HRV biofeedback resulted in greater improvements in reaction time
(p<0.05) as well as greater consistency of responses from Stroop 1 to Stroop 2 (p<0.05). BIO subjects
also made fewer mistakes in counting squares during Stroop 2 (p<0.05).
Analysis of HRV data is detailed in Chapter 4. Both groups had similar physiological responses to
laboratory induced stress in Stroop 1. In Stroop 2, the COM group responded similarly to the way
they did to Stroop 1: RF (P<0.01) and HR (p<0.05) increased; RMSSD decreased (p<0.05) and HF 
power showed a tendency to decrease (p=0.07), while LF power showed no change. However, the
BIO group responded differently in Stroop 2: while RF increased (p<0.05) and LF power (p<0.05)
decreased, HR, RMSSD and HF power showed no change. In the BIO group, RMSSD was higher in
Stroop 2 compared to Stroop 1 (p<0.05).
Analysis of the EEG is presented in Chapter 5. During the intervention, the BIO group had higher 
theta/beta at Fz (p<0.01), Cz (p<0.01) and Pz (p<0.05), higher relative theta power at Fz (p<0.01), Cz
(p<0.05) and Pz (p<0.01), and lower fronto-central relative beta power (p<0.05) than the COM
group. The groups showed different responses after the intervention with increased posterior 
theta/beta in the BIO group (p<0.01) and altered posterior relative theta (p<0.05), central relative
beta (p=0.06) and central-posterior theta/beta (p<0.01) in the post-intervention rest period.
The VAS scores revealed that the COM group felt sleepier than the BIO group after using the 
intervention (p<0.05). After testing, while there were improvements in both groups including 
increases in total relaxation scores (p<0.001) and decreased anxiety (p<0.001), HRV biofeedback 











mindfulness (p<0.05) as well as increases in the category of energized positive feelings (p<0.05). 
These changes are described in Chapter 6. 
In conclusion, these results suggest that a single 10 minute HRV biofeedback intervention led to 
improved cognitive performance, HRV changes suggestive of improved vagal modulation, EEG 
changes suggestive of increased attention together with increased relaxation both during and after 
the intervention, and greater improvements in perceived anxiety and relaxation states. HRV 
biofeedback, therefore, provides an effective, inexpensive and time efficient tool that could be a 
useful aid for improving cognitive performance in the face of stress, as well as a valuable component 














LITERATURE REVIEW: PRIOR RESEARCH AND CLINICAL 
APPLICATIONS 
1.1 INTRODUCTION AND SCOPE OF THESIS 
Psychosocial stress is increasingly prevalent in the world today. A third of people in the U.S. reported 
experiencing  ‘extreme  levels  of  stress’  in  a  poll  conducted  by  the  American  Psychological Association 
in 2007, and a fifth experienced high levels of stress a minimum of 15 days a month 1. Extreme or 
chronic stress leads to emotional distress, impaired cognitive function and increased disease. 
A very common and normal reaction to stress is anxiety 2. From 2001 to 2003, 18.1% of the US 
population experienced ongoing anxiety, 22.8% of which were classified as severe 3. Chronic 
psychological stress plays an integral role in the development of both psychological and physical 
disorders including depression 4-6, cardiovascular disease 7-9, metabolic syndrome 8;10 and possibly 
chronic respiratory disease 11. In fact, in the development of cardiovascular disease, psychological 
stress has been shown to be a risk factor of comparable or greater importance than elevated 
cholesterol 9. 
The World Health Organization reports that chronic diseases related to lifestyle, including 
predominantly cardiovascular disease, diabetes, cancer and chronic respiratory disease, are 
currently the leading cause of death globally, and are projected to increase by 15% between 2010 
and 2020 12. As the burden of chronic disease grows, it becomes increasingly important to effectively 
manage all risk factors including psychosocial stress. In addition to ill health, stress and anxiety result 
in a large financial burden from medical expenses as well as from loss of productivity and 
absenteeism. While there are many factors that contribute to the stress load of each person, a large 
component is formed by work related stress. 
The assessment and management of psychosocial stress can be complex and is often one of the 
most challenging aspects for the clinician. Part of the challenge is the difficulty in quantifying stress. 
The measurement of heart rate variability (HRV) is a potentially valuable non-invasive tool in this 











on the heart 13-15. Techniques to increase HRV may be effective in reducing stress as well as 
managing chronic disease. HRV biofeedback facilitates easy manipulation of HRV, and, therefore, 
potentially provides a valuable intervention for altering the activity of the autonomic nervous 
system. 
As a result of the high prevalence of stress and anxiety, many forms of stress management are 
available. However, many of these are lengthy, time consuming, expensive and/or require the 
involvement of a professional. Therefore, there is a need to find an effective, short duration, easily 
accessible method of managing stress that is easy to use and can be self applied. Heart rate 
variability (HRV) biofeedback shows potential as an effective stress management tool that fulfils 
these criteria. 
This literature review is divided into 4 main sections. First there is a description of stress: the
physiology of stress, the impact of stress on disease and cognitive performance, and an overview of
stress management. Secondly, there is a description of HRV and HRV biofeedback. This includes a
description of the different forms of measurement as well as a description of the physiology involved
in the control of heart rate, blood pressure, respiration and HRV. In addition, factors modulating HRV
in health and changes in HRV in stress, disease and cognitive performance are described. A final
element of this section provides a description of HRV biofeedback, as well as the effect of HRV
biofeedback on HRV, disease and cognitive performance. The third main section of this chapter is a
brief review of spectral analysis of EEG. This is important as it provides insight into the mechanisms
by which HRV biofeedback might improve performance and reduce stress and anxiety. This section
includes an interpretation of theta, alpha and beta frequency bands, and a description of the
changes in EEG that occur during cognitive performance, stress, anxiety, relaxation, meditation and














1.2 PSYCHOSOCIAL STRESS 
Stress is defined as ‘a real or implied threat to the psychological and physiological integrity’ of an 
individual 16;17. It  refers  to  a  combination  of  ‘an external stimulus called a stressor and the emotional 
and  physical  response  to  that  stimulus’  18. While physical challenges can be stressors, psychological 
factors may be even more powerful 17. Therefore, most sources use the term stress to refer to 
psychological   and   emotional   strain.   In   this   review   the   term   ‘stress’  will   be   defined   as   ‘a   state   of  
mental   or   emotional   strain   or   tension   resulting   from   adverse   or   demanding   circumstances’   as  
described by the Oxford online dictionary 19. 
The American Psychological Association has identified 3 forms of stress: acute stress, episodic acute 
stress and chronic stress 20. Acute stress occurs in response to past and future demands and is 
commonly experienced by everyone. Episodic acute stress occurs when an individual repeatedly 
experiences acute stress, and chronic stress occurs in response to ongoing high pressures. 
The healthy body is able to adapt in response to an acute stressor 21. This is beneficial in many 
situations. However, when stress is chronic, the body loses its ability to adapt and physiological 
responses become out of proportion to stressors 21. Damage or disease occurs in chronic stress or 
when an appropriate acute stress response is ongoing 21. In addition to the specific responses which 
may occur in response to different stressors, stress also results in a nonspecific generalised response 
that aims to prepare the body for fight or flight. Hans Selye named this the general adaptation 
syndrome 22 and he described it as having 3 stages including the ‘general   alarm   reaction’,  
‘adaptation’  and  when  the  stress  is  ongoing,  ‘exhaustion’. 
There is considerable variation in how different individuals perceive and respond to potentially 
stressful situations.  Some people may experience a particular incident as stressful while others may 
not. People may also have different physiological responses to stressors. These different responses 
are influenced by genetics, past experiences, society and psychological factors such as anxiety 23. 
Common symptoms of stress include the symptoms of increased sympathetic activation 24 which will 












1.2.1 Physiology of the stress response 
There are 2 main systems that generate the stress response: the sympathetic component of the 
autonomic nervous system and the hypothalamo-pituitary-adrenocortical (HPA) axis. 
1.2.1.1 The sympathetic component of the autonomic nervous system 
This is the main system activating the body in response to acute stressful incidents 25. Information
regarding stressors is relayed via the sensory and visual afferents of the peripheral nervous system
to the central nervous system. The locus ceruleus-norepinephrine (LC/NE) system in the pons and
medulla is the main control centre for the efferent sympathetic/adrenomedullary system 25. In
addition to sending impulses to the periphery, the LC/NE system releases epinephrine directly into
the brain regulating arousal and attention 26-29, increasing alertness and decreasing neurovegetative
functions 25.
Efferent impulses stimulate the adrenal medulla to release epinephrine and norepinephrine. These
hormones reinforce the direct actions of the sympathetic nervous system. Epinephrine and
norepinephrine bind to alpha and beta adrenergic receptors and thereby influence target organs.
Activation of the sympathetic nervous system results in increased arousal, increased sweat 
secretion, pupil dilation, bronchiolar dilation, increased rate and force of cardiac contraction, blood
vessel constriction and therefore increased blood pressure, increased catabolism and redirection of 
blood flow to the muscles, heart and brain, as well as decreased gastrointestinal tract (GIT) motility
and relaxation of the gallbladder and urinary bladder 24.
1.2.1.2 The hypothalamo pituitary adrenal (HPA) axis
The main control centre for the HPA axis is the paraventricular hypothalamic nucleus (PVN) 25. The 
hypophysiotropic neurons in the medial parvocellular division of the PVN produce 
adrenocorticotropic hormone (ACTH) releasing factors 30;31 including corticotropin releasing 
hormone (CRH) and arginine vasopressin (AVP). AVP acts synergistically with CRH to stimulate the 
release of ACTH from the anterior pituitary gland 30 into the systemic circulation. ACTH then 
stimulates the release of cortisol from the zona fasciculata and zona reticularis of the adrenal cortex. 
Under normal non-stressful conditions both CRH and AVP are released in pulses every 20 to 30 
minutes 32. The amplitude of these pulses increases in the morning resulting in a diurnal circadian 













disruption of homeostasis or in anticipation of a stressful event, the pulsatile release of CRH and AVP 
increases in frequency and amplitude resulting in increased secretion of ACTH and increased release 
of adrenal corticosteroids 35;36. 
Cortisol crosses the blood brain barrier and stimulates glucocorticoid (GRs) and mineralocorticoid 
receptors (MRs) within the brain 37;38. MRs have a high affinity for glucocorticoids 39, while GRs have 
a low affinity 40-42. During the circadian trough cortisol occupies mainly the MRs, while during the 
circadian peak and in times of stress, MRs are saturated and most of the GRs are occupied 39-42. This 
is relevant in understanding the impact of different levels of stress on memory as will be described 
below. Activation of MRs provides negative feedback resulting in inhibition of the PVN, while 
activation of GRs after stress inhibits the effect of the MRs and therefore activates the PVN 42. 
The effects of cortisol tend to restore homeostasis but are generally catabolic in nature 36. Fuel 
stores are mobilised resulting in an increase in blood glucose, amino acid and fatty acid 
concentrations, bone and muscle growth is inhibited, immunity and reproductive function 
suppressed and sympathetic mediated vasoconstriction increased 24;43;44. These changes in response 
to stress differ depending on both age 45 and sex 46-48;48-53. 
1.2.2 The effect of stress on disease 
Adverse psychological stress plays an integral role in the development of both psychological 
disorders such as depression 4-6 and negative mood 54, and physical disorders. Physical disease states 
associated with increased psychological stress are shown in Table 1.1 below. To date, cardiovascular 
disease has been the most extensively studied. 
Adverse psychological stress leads to increased risk of cardiovascular disease and mortality both 
directly 55-58 and indirectly as a result of increased unhealthy behaviours 59. Chronic stress is a risk 
factor for the development of hypertension 8;60;61 and coronary artery disease (CAD) 62;63, as well as a 
trigger for myocardial ischaemia 64-68 and infarction 56;68-71. Ischaemia induced by mental stress 
generally leads to higher rates of subsequent fatal cardiac events 72;73. The acute increase in blood 
pressure seen in response to mental stress 54;60;65;74  is similar to that caused by exercise 65, and the 
impact of stress on ischaemic events may be comparable to the impact of strenuous physical 













diseased coronary vessels 76 and abnormal ventricular wall motion in patients with CAD 65. It also 
causes increased myocardial oxygen demand and increased systemic vascular resistance 77.  
Table 1.1 Physical disease states that are associated with increased psychological stress 
Disease states  
Cardiovascular disease  Hypertension 8;60;61 
 Coronary artery disease 62;63;76 
 Accelerated atherosclerosis 8 
 Abnormal ventricular wall motion in patients with CAD 65 
 Increased myocardial oxygen demand 77 
 Increased systemic vascular resistance 77  
 Myocardial ischaemia 64-68 and infarction 56;68-71 
 Takotsubo or stress cardiomyopathy 78-85 
 Atrial fibrillation 86 
 Ventricular tachyarrhythmia 87 
 Ventricular fibrillation 88;89 
Metabolic Syndrome 8;10 Hyperlipidaemia 90 (effect of high cortisol) 
 Abdominal fat deposition 91 (effect of high cortisol) 
 Risk of diabetes 90 (effect of high cortisol) 
Chronic respiratory disease Asthma 11 
Neurological disease Neurodegenerative diseases 92 
Endocrine disease Suppression of growth hormone 24 
 Suppression of sex steroids 24 
 
Psychological stress may precipitate a cardiomyopathy known as a Takotsubo or stress 
cardiomyopathy 78-85. This consists of a reversible 80;83;85 left ventricular apical wall motion 
abnormality in the absence of underlying coronary artery disease. It is thought that the primary 
cause is a catecholamine surge which leads to myocardial stunning 83. Samuels suggests that severe 











Arrythmias including atrial fibrillation 86, ventricular tachycardia (VT) 87, and potentially lethal 
ventricular fibrillation (VF) 88;89 are commonly triggered by psychological stress. In fact, the major 
mechanism of sudden cardiac death after acute emotional stress may be related to arrythmias 
following subendocardial myofibrillar degeneration 93. Patients with idiopathic QT prolongation are 
particularly sensitive to these life threatening stress induced arrythmias 94. 
Chronic work stress is a risk factor for metabolic syndrome 8;10, both as an independent risk factor 10 
and by leading to increased unhealthy lifestyle choices 95;96. Furthermore, high cortisol levels have 
been shown to lead to hyperlipidaemia 90, increased abdominal fat deposition 91 and increased risk 
of diabetes 90. 
Psychological stress has a negative impact on asthma 11, however the exact mechanisms are not
currently known 97;98. Chronic stress also results in increased development of neurodegenerative
diseases 92. It leads to suppression of growth hormone and sex steroids 24, and excessive 
glucocorticoid secretion has been identified as a major factor in the ageing process 99;100. While the
immune system is activated during acute stress 17;101-104, it is suppressed in response to chronic stress
104-107.
1.2.3 The effect of stress on cognition and performance
While it is easy to investigate the effect of acute stress on cognition in humans, it is not ethical to
induce chronic stress. Thus most studies exploring chronic stress in humans have evaluated groups
of people who have been exposed to high levels of cortisol over time. High levels of stress and
glucocorticoids have a large impact on memory as well as other components of cognition. For a full
review of the effect of glucocorticosteroids on cognition see Belanoff et al 108.
High levels of cortisol have been shown to impair cognitive function 109-111, attention 112;113 and 
learning 114;115. Lupien and McEwen 116 describe the relationship between plasma glucocorticoids and 
memory performance as an inverted U-shaped dose-response curve. Low and moderate levels of 
glucocorticoids 117;118 together with high catecholamines result in increased memory formation 119-121 
while high or chronically increased levels inhibit memory 17;116;122. 
Studies on stress have also shown a dose related response. Acute stress and low levels of ongoing 











catecholamines and glucocorticoids 119;124. However, this usually only occurs when the material to be 
remembered is directly related to the stressful stimulus 126-128. In addition, the action of 
norepinephrine enables the individual to focus their attention more clearly 129. 
Conversely, acute and chronic stress have been shown to impair cognitive function 130-132, with 
impaired memory 45;114;115;117;118;124;130;133-144, including working memory 145, impaired set shifting 146 
and cognitive flexibility 147, and impaired attention 148 suggestive of frontal cortex dysfunction 149. In 
addition, people tend to work more slowly and make more errors 150 and have increased error 
related brain activity151. Other studies have shown no influence on memory 120;124;128;152-155. 
Fortunately, the memory impairment caused by acute stress is short term and reversible 17, and 
bringing glucocorticoid levels back to normal improves cognition 122;156;157. 
1.2.4 Stress management 
Given the high prevalence of stress, the severity of the associated diseases and the cost of disease
697;698;699;701 and associated lack of productivity 700, it is important to find methods to manage stress
effectively. There are many different stress management techniques and each person needs to find
the method that is right for him/her. Effective stress management involves techniques that reduce
the stressors to which one is exposed, as well as techniques that increase our ability to manage or
cope with the unavoidable stressors.
Reducing stressors by learning life skills such as good planning and time management, financial
planning and management, and conflict resolution, leads to a reduction in stress 158. However,
nowadays much stress is unavoidable and so it is particularly important to find effective tools to
manage stress. Many people use allopathic or natural medication to manage the associated anxiety
or depression and to improve sleep. Cognitive therapy 159;160, relaxation training 161;162, body therapy
such as massage 163;164, exercise 165 and yoga 160;166 are also used by many people to manage stress.
Additionally, hobbies such as listening to music, reading, art or spending time in nature can be
effective. Listening to relaxing and classical music has been shown to decrease state anxiety 167;168
and increase feelings of relaxation 169.
Meditation is also commonly used as a stress management technique and can include both 
relaxation training and specific breathing techniques. There are two main styles of meditation, 











both 170;171. Concentrative meditation includes forms of yogic and Buddhist meditations and, in 
modern medicine, transcendental meditation 170;172, while mindfulness meditations include Zen, 
Vipassana and, in modern medicine, mindfulness-based stress reduction (MBSR) 170;172. The main 
psychological parameter affected by meditation is attention 173. Providing a single focus of attention 
has been shown to be the most common way to relax 174. Meditation decreases experienced stress 
175-184, decreases sympathetic activity 185-193 and increases parasympathetic activity 193;194 . In
addition, it results in decreased anxiety experienced in anxiety disorders 172 and increased cognitive
performance 195.
Relatively recently, biofeedback has been used in the management of insomnia, anxiety and stress.
Specifically, HRV biofeedback shows promise in the management of stress 196 and anxiety 195;197-199. 
HRV biofeedback is similar to a concentrative meditation in that it is focused on a specific sensory
activity 170. However, it is different from a concentrative meditation in that in addition to observing, 
one is actively controlling the breath in response to an external biofeedback stimulus.
Most relaxation techniques result in a non-specific relaxation characterised by decreased
sympathetic arousal 200 and lead to a reduction of stress and anxiety 177;201;202. However, different
techniques may produce different specific effects 203;204. Davidson has differentiated between
cognitive and somatic relaxation effects 205, while Smith has identified 4 different relaxation states
including mindfulness, energized positive feelings, basic relaxation and transcendence 206.












1.3 HEART RATE VARIABILITY 
Heart rate variability is the cyclical change in heart rate over time 207. As heart rate is regulated by 
the parasympathetic and sympathetic components of the nervous system, measurement of HRV 
provides a valuable quantitative marker of the effect of the autonomic nervous system on the heart 
13-15;208. It is therefore a useful tool in the measurement of the physiological effect of stress and
relaxation.
Observation of HRV was first documented in the mid-1800s and observation of respiratory sinus
arrythmia (RSA), which is the cyclical change in heart rate that occurs in synchrony with respiration,
in the mid-1900s 209. However, research in HRV only started in the 1960s 210, most likely as a result of 
technical advances which allowed accurate and reliable measurement of cardiac electrical activity.
At the time, while many researchers viewed HRV as an error as a result of poor experimental
technique 209, others had identified the importance of its clinical application 15. Research on HRV was
being conducted in cardiology and obstetrics in the USA 209, and in HRV regulation through
biofeedback in Russia 210. Technical advances continued, and power spectral analysis of HRV started
in the late 70s and early 80s 207;211.
Recently, there has been an exponential increase in research on the physiology of HRV, the changes
in HRV in health and disease, as well as the modification of HRV with biofeedback and the
application of HRV biofeedback. While recording HRV is uncomplicated and non-invasive, there is
still much debate regarding the interpretation of the autonomic effect on the different measures of
HRV. Therefore, it is perhaps important to understand these limitations when the literature is
reviewed and interpreted.
1.3.1 Measurement of HRV 
Oscillations in HRV can be quantified using both time and frequency domain measures. These 
different measures reflect changes in different aspects of the underlying neural regulation 212-214. The 
Task Force of the European Society of Cardiology and the North America Society of Pacing and 
Electrophysiology have published a comprehensive guideline document on the measurement and 
interpretation of HRV 15. For both time and frequency domain measurements, it is important that 
recording segments of similar length are compared as the total variability of changes in heart rate 











1.3.1.1 Time domain measures 
Commonly used time domain variables include SDNN, SDANN, RMSSD, NN50 and pNN50. SDNN is 
the standard deviation of the NN interval or normal-to-normal RR interval. It ‘reflects all the cyclic 
components responsible for variability in the period of recording’ 15 and is mathematically equal to 
the total spectral power 15. As the length of recording decreases, SDNN reflects higher frequencies. 
SDANN is the standard deviation of the average NN interval which has been calculated over short 
periods. This is typically done using periods of 5 minutes over a 24 hour recording, and it provides an 
estimate of longer cycles in HRV 15. 
RMSSD is the root mean square of the successive differences of the RR intervals and reflects the
variability in the change in NN interval 15. High frequency oscillations will cause NN to change faster
resulting in greater changes in RMSSD, while low frequency oscillations will result in slower changes
in NN and thus less change in RMSSD. Therefore, while RMSSD is affected by all oscillations at all
frequencies 215, higher frequencies will have a greater impact 15;216-218. This is the reason why many
studies have shown a high correlation between RMSSD and high frequency power in the cardiac 
spectrogram 15;209;215;219 and suggest that RMSSD is a good indicator of cardiac vagal control 15;209;219. 
However, as RMSSD reflects all frequencies it may also reflect sympathetic influences 215 and
therefore not be a pure index of vagal cardiac control. While RMSSD is less sensitive to variations in
respiratory patterns 220, it is more reliable to compare data at similar respiratory frequencies.
The NN50 is the number of successive NN intervals which have a difference of greater than 50ms
and the pNN50 is the NN50 as a proportion of the total number of NN intervals 15. Both of these 
correlate highly with HF cardiac spectral power 15.
1.3.1.2 Frequency domain measures 
Elghozi et al 221 classified oscillations in HRV into 7 broad groups ranging from the largest oscillations 
to the smallest: age related, seasonal changes, circadian rhythms, hourly rhythms, minute changes 
(also called very low frequency (VLF)), low frequency (LF) fluctuations and high frequency (HF) 
fluctuations. 
The power spectral density of HRV in short term recordings (2 – 5 minutes) consists of the last 3 of 
these spectral components: VLF (<0.04 Hz), LF (0.04 to 0.15 Hz) and HF (0.15 to 0.4 Hz) oscillations 











While VLF appears to be related to the control of temperature and vascular tone 208;222;223, it is also 
affected by the renin-angiotensin-aldosterone system 207;224, and can be influenced by both 
sympathetic 209 and parasympathetic 224 activity. While some studies do measure VLF, the 
physiological explanation is not well understood and so VLF is generally not interpreted 208 and will 
not be reported in this thesis. 
Therefore, the two main frequency bands in short-term recordings include the LF and HF bands. HF
is often referred to as respiratory frequency, as the predominant HF peak occurs at the same
frequency as respiratory frequency 209;225;226. HF HRV is also referred to as RSA and thus HF spectral
power is commonly used as a tool to measure RSA 227. However, while the average respiratory
frequency of normal resting adults is within the HF band, there are instances, especially during
controlled breathing, when people breathe in the LF band.  RSA can, therefore, affect both HF and LF 
HRV 228.
Another measure of HRV based on frequency domain measures is the LF/HF ratio which has been
suggested to represent the sympathovagal balance 208. HF power reflects cardiac parasympathetic
activity 225;229;230, and initially it was believed that LF power represented sympathetic activity
exclusively 213;225;231-234. Thus many researchers used the LF/HF ratio to give an indication of
sympathovagal balance, thinking that as one was active the other would be inhibited 225;235. 
However, as LF can be affected by sympathetic and vagal activity either directly or indirectly as 
described below, this interpretation of the LF/HF ratio has been questioned 236. Simultaneous
analysis of respiratory frequency reduces the error in the interpretation of the LF/HF ratio 228;237; 
however results should still be interpreted with caution.
1.3.2 Control of heart rate, blood pressure and respiration 
Heart rate variability is affected by factors regulating heart rate, including changes in blood pressure 
and respiration. 
1.3.2.1 Heart rate and blood pressure 
In the healthy human, heart rate is determined by the automatic firing frequency of the sinoatrial 
node in the right atrium. This is modulated by the balance between efferent sympathetic and 
parasympathetic (vagal) flow to the heart 238. Autonomic flow to the heart is mainly regulated by 











The most important peripheral oscillator which acts via the medullary centres is the baroreflex 
system. This is a resonant 239, closed loop system 240;241 which maintains blood pressure homeostasis 
by altering the sympathetic flow to the vasculature and the vagal flow to the heart 242-244. Arterial 
baroreceptors in the walls of the aortic arch and carotid arteries contain stretch receptors which 
respond to changes in arterial pressure. Afferent impulses then travel in the vagus and 
glossopharyngeal nerves to the nucleus tractus solitarius (NTS) 245. 
There are two components of the baroreflex system, one regulating vascular tone and one heart rate
246;247. The vasomotor centre or medullary sympathetic centre regulates changes in the sympathetic
outflow to the vasculature 246;248;249 controlling vasomotor tone 250;251. This centre consists of a
depressor area in the caudal ventrolateral medulla (CVLM) and pressor area in the rostral
ventrolateral medulla (RVLM). The RVLM contains sympathoexcitatory neurons which maintain tonic
sympathetic vasomotor activity and resting arterial pressure 252. Stimulation of the arterial
baroreceptors causes stimulation of the NTS, which stimulates the depressor area in the CVLM. This
in turn inhibits the pressor area in the RVLM, resulting in an inversely proportional change in
vascular sympathetic firing 253-255. Increased baroreflex stimulation results in slow sympathetic
withdrawal of 3-10 s to the blood vessels 246 and, therefore, a decrease in vascular tone 256, while
decreased baroreflex stimulation results in increased sympathetic activity and vasoconstriction
250;251.
In response to increased baroreceptor activation, the NTS also stimulates the medullary
parasympathetic centre or cardio inhibitory centre (CIC) 257. This centre is the origin of the vagus
nerve which supplies the parasympathetic fibres to the heart. These arise largely from the nucleus
ambiguus, but also from the dorsal motor nucleus of the vagus 257. Stimulation of the baroreceptors
results in a rapid increase in cardiac vagal flow taking less than 1 second 246 and resulting in a 
baroreflex mediated decrease in heart rate and increase in HRV 258;259. The cardiac accelerator centre
in the RVLM regulates the sympathetic flow to the heart 260. This centre is activated by higher
centres in response to stress or exercise 260.
The relationship between oscillations in heart rate and blood pressure reflects the baroreflex action 
226;246;247;261;262. Baroreflex sensitivity (BRS) gives an indication of the ability of the baroreflex to 
respond to changes in blood pressure, and is expressed as the change in heart rate that occurs as a 












The main respiratory centres are also situated in the medulla. The medullary respiratory centre is 
located in the ventrolateral medulla (VLM). Inspiration activates pulmonary stretch receptors. 
Afferent flow from these receptors travels via the vagal nerve to the nucleus tractus solitarius which 
then inhibits the medullary respiratory centre. Efferent flow via the phrenic and intercostal nerves 
decreases, inhibiting inspiration. Simultaneously, inspiration results in inhibition of the cardio 
inhibitory centre via the respiratory centre 265, thus resulting in decreased vagal flow to the sinus 
node 266. 
While the medulla contains the primary control centres that govern respiration, heart rate and
vasomotor tone, these are modified by higher centres. In addition to the afferent nerve impulses
from arterial baroreceptors, pulmonary stretch receptors and chemoreceptors, impulses from higher
centres converge on the NTS 260. For example, the NTS receives input from the dorsomedial
hypothalamic nucleus in response to acute stress activation of the amygdala.
1.3.3 Control of HRV 
A summary of the regulation of the low and high frequency components of HRV is shown in Figure
1.1 below. 
LF oscillations in HRV are primarily generated by resonance in the arterial baroreflex loop
226;246;261;267. Perturbations of blood pressure stimulate the arterial baroreceptors in the aortic arch
and carotid sinus. Afferent impulses from these receptors converge together with impulses from
higher centres on the nucleus tractus solitarius in the medulla 245. Increased blood pressure results in
inhibition of the tonically active sympathetic outflow from the medullary vasomotor centre to the 
vasculature 253-255, decreasing vasomotor tone 256 and blood pressure. Simultaneously, the medullary
cardio inhibitory area is activated, increasing vagal flow to the heart 246, decreasing heart rate and
increasing HRV 258;259. The time delay between the initial increase and the resulting change in blood
pressure sets up a new blood pressure oscillation. When the initial and resultant blood pressure
oscillations are in phase, resonance occurs 241;248;268. This resonant oscillation is known as the Mayer
wave 211 and in humans is most commonly seen at 0.1Hz 246;248;261;269 forming the main component of
the LF band of blood pressure. Mayer waves stimulate the baroreflex causing vagally mediated LF











decreases in heart rate lower the cardiac output which, together with decreased vasomotor tone, 
alters blood pressure, stimulating the baroreceptors and beginning the cycle again. 
Figure 1.1 Schematic summary of the key factors regulating low and high frequency heart rate 
variability 
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Alterations in vasomotor tone and LF blood pressure variability are directly regulated by the 
sympathetic nervous system 270-273, while LF HRV at rest is influenced directly by the parasympathetic 
system 207;224;274;276-278 and indirectly rather than directly 207;224;251;271;277 by the sympathetic system. 
Therefore LF cardiac spectral power reflects both sympathetic and parasympathetic influences 
15;207;209;233;246;271;276;279-285. 
Respiratory sinus arrhythmia (RSA), the cyclical change in heart rate that occurs in synchrony with
respiration, affects both HF and LF HRV oscillations depending on the frequency of respiration.
Respiration at a rate of about 6 breaths per minute or 0.1 Hz 14;223;226;246;262;286 results in resonance
between the respiratory and intrinsic baroreflex oscillations 287 and is known as resonance
frequency. When this occurs, RSA is maximal 14 and forms the major component of the HRV
spectrogram 288. Peak RSA occurs at different respiratory rates in different individuals 288 with 
resonance frequency occurring in a range from 4.5 to 6.5 breaths/min 288.
At resonance frequency, respiration leads to changes in HRV in the LF range. RSA is mediated by
gating of preganglionic vagal cardiac neural activity 289 in response to central oscillations 290, 
pulmonary and atrial stretch reflexes 237;272 and the arterial baroreflex 246;274;291-293. In addition, it is
affected by the intrinsic mechanical myocardial stretch in response to respiration 294. Inspiration
stimulates stretch receptors resulting in inhibition of the medullary respiratory centre and inhibition
of the cardio inhibitory centre decreasing cardiac vagal flow 266, and mechanical stretch directly
stretches the right atrium affecting the SA node 295 causing around 4% of RSA in healthy people 296. In
both cases, inspiration results in an increase in heart rate and increased RSA 266;296.
In addition, inspiration decreases intrathoracic pressure 209, which increases venous return and atrial
filling 226;246, stroke volume 297;298 and cardiac output leading to increased arterial pressure 267;298. This 
results in decreased heart rate and vascular tone via the baroreflex. At resonance frequency,
respiratory rate and heart rate oscillate in phase, while heart rate and blood pressure are 180° or
half a cycle out of phase 223;299. Because of this time delay between the increase in blood pressure 
and heart rate, the heart rate will increase in response to decreased intrathoracic pressure at the
same time as the increase in heart rate in response to activation of the stretch receptors and
mechanical stretch, resulting in maximal RSA at resonance frequency 14.
HF HRV oscillations are regulated by efferent vagal flow 207;224;225;229;230;262;274;276;278;300 and are not 











stimulation is too slow 262. Similarly, sympathetic activity has an indirect 294;302 rather than direct 
207;233;276;277;303;304 effect on RSA. Cyclical vagal discharge from the medulla 207;229;233;276;277;300;303-308 is 
the final generator of RSA, and contributes to the generation of LF oscillations when breathing at 
resonance frequency and HF oscillations when breathing is faster than 9 breathes/minute. The 
magnitude of RSA gives an indication of cardiac vagal activity or tone 207-209;229;230;276;304;309-317. RSA 
increases as cardiac vagal activity increases 229;230 and decreases as vagal activity decreases 
207;229;230;272;276;300;306;318. 
While the vagus regulates both heart rate and RSA 304, there are times when they do not co-vary. In
fact, large RSA amplitude is healthy while severe bradycardia is potentially lethal. Porges has called
this  the  ‘vagal paradox’  319 and has explained it by suggesting that there are 2 branches to the vagus, 
one causing RSA and the other bradycardia 319.   This   ‘polyvagal theory’   319 identifies 3 different
subsystems of autonomic control. The first is related to social communication, and consists of the
myelinated vagus which originates in the nucleus ambiguus and causes RSA. This system inhibits the
sympathetic influence on the heart and dampens the HPA axis. The second is responsible for
mobilization of the body and depends on the sympathetic system. The third results in immobilization
and consists of the unmyelinated vagus originating in the dorsal motor nucleus. These 3 subsystems
are recruited in order of hierarchy. When the environment is safe, the social communication system
is active. In danger, if the social communication system is ineffective, the mobilization system is
activated. Finally, the primitive immobilization system is activated.
Finally, central oscillations in the respiratory and cardiovascular medullary regulatory centres
contribute to both low 207;225;301;320;321 and high frequency 225;322 oscillations in HRV. In conclusion, the
regulation of HRV is complex and depends on both peripheral and central factors 226;246;261. HRV
reflects the ability of the cardiovascular system to adapt to both internal and external demands and
increased variability is a sign of good health 323;324.
1.3.4 Modulators of HRV in health 
HRV is modulated by many factors including age, sex, physical position, sleep and exercise. It has 
been shown to decrease with increasing age 325;326 although most studies have found that the decline 
levels out after 40 years 326-329. This decrease shows different patterns for different measures 328;330. 
HF power decreases linearly from 9 to 28 years 328 and then remains stable 326, while LF power 











RSA increases up to early adulthood and then also decreases with increasing age 331. Baroreflex 
function is also negatively correlated with age 332. These findings may be explained as with increasing 
age, muscle sympathetic nerve activity (MSNA) increases 333, cardiac vagal tone changes 334 and HRV 
responsiveness to parasympathetic stimulation decreases 335. 
HRV shows sex specific variations which are also modulated by age. Women under the age of 30 
have lower SDNN and RMSSD than men, and the differences slowly decrease until none are evident 
after 50 years of age 330. However, when examining LF and HF power, women around the age of 50 
have lower LF and higher HF power than men 336. Furthermore, MSNA is lower in women under 50 
years and similar between men and women 50 years and older 333. 
The position of the body also influences HRV. RR intervals 224;337, HF power 212;337, RSA 233;276 and
baroreflex gain 212 all decrease, while LF power 212;225;332 and the LF/HF ratio 212 increase with
increasing tilt angle and in the upright position. In supine rest, baroreflex induced vagal flow
accounts for most of the LF heart rate oscillations 275. However as the body becomes more upright,
sympathetic flow increases 262;337-339 and vagal flow decreases 337. In the upright position, the
increased sympathetic flow overrides the respiratory gating of the cardiac inhibitory centre and so
RSA decreases. Even so, HF power is greater than LF power when breathing in the HF range 337.
HRV during REM sleep is similar to during waking 340. However, during non-REM sleep, RR amplitude
341 and HF power 340;341 increase and LF power decreases 340. This possibly occurs as sympathetic
activity is greater during both REM sleep and waking 340. While the increase in RR amplitude is seen
in all ages, the increase in HF power is seen mainly in young subjects 341.
Extensive reviews have been conducted on the changes in measures of HRV during acute exercise, as 
a result of exercise training and in overtraining, and all agree that results are conflicting and 
inconclusive 342-344. While measures of HRV are valuable indicators of the autonomic control of the 
heart at rest, they do not behave as expected during exercise 342. Furthermore, spectral analysis 
requires stationary data which is not possible during exercise 343;345 making interpretation difficult 
and misleading especially during high exercise intensities 342. It is concluded that analysis of HRV, 












While most cross-sectional studies show higher HRV in trained subjects 342;344 indicating greater 
cardiac vagal tone 343, results from both cross-sectional and longitudinal studies are conflicting 342-344. 
However, in chronic disease, exercise training has been shown to increase HRV 346-349 as well as 
baroreflex sensitivity 346 at rest in patients recovering from myocardial infarction. These changes 
persisted for the following year 348 and were associated with lower cardiac mortality in the following 
10 years 346. Further research is required to validate alternative forms of HRV analysis during 
exercise, as well as to investigate the changes in HRV after exercise training especially in patients 
with chronic disease. 
1.3.5 Changes in HRV during stress and relaxation 
Heart rate variability is also affected by stress and anxiety. Both acute and chronic psychological
stress lead to decreased amplitude of the RR intervals 212;350;351, decreased SDNN 62;352, RMSSD 353, 
RSA 354;355 and HF power 212;352;356-360, and increased LF power 212;225;352;359 and LF/HF ratios 212;351;352;358-
362. HF power also decreases during acute 350 and chronic anxiety 350;363. Both baroreflex gain 212;364
and sensitivity 308;316;365;366 decrease and the set point of the baroreceptor-heart rate reflex 365;367
changes. In addition, stress leads to an increase in HR 368;369 and BP 368;369 including both systolic (SBP)
and diastolic blood pressure (DBP) 359.
Porges attributes the decrease in measures of HRV during stress to the alteration of the 
physiological responses that occurs during chronic stress 317.The decrease in HF power indicates
decreased vagal activity 352;357;358, and the increase in HR and BP both occur as a result of increased
sympathetic activity 368;369. Increased LF power most likely reflects both a decrease in vagal activity
and increase in sympathetic activity. The hypothalamus and other higher centres modulate the
baroreflex in response to stressful stimuli, potentially affecting all HRV variables 257.
In the period immediately after acute stress, a rebound in vagal activity may cause RMSSD to 
increase to higher than baseline and HR and SBP to be lower 316. RMSSD is generally greatest during 
the first minute of recovery suggesting that HR recovery is vagally mediated 316. People with 
decreased HR recovery may also have decreased HR responses to stress 370. 
During relaxation, RSA 371 and baroreflex sensitivity 365 increase and responsiveness of the end 
organs to norepinephrine decreases 372. Meditation increases HF and decreases LF power and the 













restructuring and mental relaxation programs reversed the increased LF and decreased HF 
components of HRV that were documented in response to work stress 158. 
1.3.6 Changes in HRV in disease 
Changes in HRV are seen in many disease states and are often valuable in predicting prognosis 15. 
The association of HRV with cardiovascular disorders is the most extensively studied to date. 
1.3.6.1 Cardiovascular disease 
The pathophysiology of many cardiovascular diseases is related, at least in part, to low vagal tone, as 
healthy stable cardiac function requires adequate vagal modulation of heart rate and conduction 
velocity 374. Therefore, cardiovascular disease is associated with decreases in both time and 
frequency domain measures of HRV. While decreases in all measures of HRV may reflect decreased 
cardiac vagal tone, RMSSD, pNN50 and HF spectral power are specifically indicative of vagal 
modulation 15. 
Changes in measures of HRV associated with different cardiovascular diseases are shown in Table 1.2 
below. Hypertension is associated with low SDNN 375, low RSA 376 and abnormal baroreflex function 
377 which has been proposed as a factor in its development. Low SDNN, RMSSD, pNN50, LF and HF 
cardiac spectral power are all associated with increased risk of CAD and its complications 378;379. 
Specifically, low SDNN may predict the development of CAD 379, and is associated with CAD-related 
sudden death 380, while low HF power correlates with the severity of atherosclerosis 381. 
Low SDNN is also associated with increased risk of ischaemia and infarction 382. LF and HF spectral 
power decrease before the onset of ischaemia 64, and are lower immediately after 383 and 2 weeks 
after 384 myocardial infarction. HF power is particularly low when ischaemia follows high mental 
activity 64. When spectral components are expressed as normalised units, the percentage of LF 
power is higher and HF power lower 2 weeks after MI 385. Both HF and LF power recover maximally 
but not completely over the following year 384-386. 
After myocardial infarction, HRV can be used as a prognostic factor for risk stratification and 
management 15. Low HRV is indicative of increased risk of cardiac mortality 387-392 and is related to 
sudden cardiac death 393. The general consensus is that HRV should be measured approximately 1 













SDNN of less than 50ms have a higher risk of mortality than those with SDNN greater than 100ms 
15;389. 
Low SDNN is associated with symptomatic patients with hypertrophic cardiomyopathy 394, and low 
SDNN 382, TF 395, HF and LF power 396;397 with heart failure 382. Both HF and LF power are positively 
correlated with left ventricular ejection fraction 396 and cardiac output 398, and negatively correlated 
with increasing severity of cardiac failure 399. Low SDNN 382 and low LF 395;400 power are indicators of 
poor prognosis, with an SDNN lower than 100 ms indicating increased mortality 400. 
Furthermore, low HRV is associated with increased risk of arrythmias as well as increased mortality. 
Low SDNN and HF power are seen prior to the onset of sustained VT and VF 401 as well as atrial 
flutter 402 supporting the suggestion that decreased   vagal   stimulation   results   in   ‘cardiac   electrical 
instability’  which   increases  the  risk  of  arrhythmias   15. Low SDNN, pNN50, LF and HF power are risk 
factors for sustained VT 380;394;401 as well as death from cardiovascular disease 379;382;403, and low 
SDNN, LF and HF power are risk factors for non-cardiac death 403. 
1.3.6.2 Metabolic syndrome 
Changes in HRV associated with metabolic syndrome are shown in Table 1.2. Metabolic syndrome is 
associated with decreased HRV including low SDNN, HF and LF spectral power 404-406 independent of 
fasting glucose levels 404. As the number of metabolic components increases, HRV measures 
decrease 405. These same HRV variables are inversely correlated with plasma glucose 407, and are low 
in diabetes 404;407-410. Decreased HRV indicates abnormalities of the autonomic nervous system which 
may occur early in diabetes 411 and is associated with a high risk of morbidity and mortality 14;412-415. 
Low HRV may also precede the clinical expression of autonomic neuropathy 216;416;417 and is therefore 
a useful screening tool 15. 
1.3.6.3 Chronic pulmonary disease 
Chronic obstructive pulmonary disease (COPD) has been associated with decreased HRV including 
low SDNN 418, RMSSD 419 and LF and HF spectral power 419. This suggests abnormal cardiac autonomic 
modulation 418;420 including decreased vagal activity 419. A correlation has been found between these 














Table 1.2 Changes in measures of HRV associated with cardiovascular disease states, metabolic syndrome and chronic respiratory disease states 
 
CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; SDNN = standard deviation of the normal to normal RR intervals; ms = milliseconds; RMSSD 
= root mean square of successive differences of RR intervals; pNN50 = the number of successive NN intervals which have a difference of greater than 50ms as a proportion 
of the total number of NN intervals LF, HF and TF = power of the RR interval spectrum in low frequency, high frequency and total frequency ranges respectively; RSA = 
respiratory sinus arrythmia. 
 SDNN  RMSSD pNN50 LF  HF TF RSA 
Cardiovascular disease        
Hypertension ↓  375      ↓376 
CAD  ↓  378-380 ↓  378;379 ↓  378;379 ↓  378;379 ↓  378;379;381   
Ischaemia  ↓  382   ↓before  onset  
64 
 
↓before  onset  64 
   
Infarction  ↓  382   ↓  immediately  after  
383 
↓  2  weeks  after  384 
↓  immediately  after  383 
↓  2  weeks  after  384   
Cardiomyopathy ↓  394       
Heart failure ↓  
382 
↓  poor  prognosis  382   
↓396-399 
↓poor  prognosis  395;400 
 
↓  396-399 ↓  395  
Arrythmias         
     Ventricular Tachycardia ↓  prior  to  onset  
401 
↓  380;394;401  ↓  
380;394;401 ↓  380;394;401 ↓  prior  to  onset  
401 
↓  380;394;401   
     Ventricular Fibrillation ↓  prior  to  onset  401    ↓  prior  to  onset  401   
     Atrial Fibrillation ↓  prior  to  onset  402    ↓  prior  to  onset  402   
Cardiac mortality ↓  379;382;389;392;403  ↓  379;382;403 ↓  379;382;403 ↓  379;382;403   
Metabolic Syndrome ↓  404-406   ↓  404-406 ↓  404-406   
Diabetes  ↓  404;407-410   ↓  404;407-410 ↓  404;407-410   
Chronic Respiratory disease        













1.3.6.4 Other  
Changes in HRV are also seen in psychiatric and neurological diseases. Severe major depression has 
been associated with decreased RMSSD 421 and decreased HF power 421;422 , as well as increased 
LF/HF ratios 421;423 at rest and in response to mental stress 424, while patients post- myocardial 
infarction with depression have lower LF power 425. Patients with generalised anxiety disorder have 
decreased HF power  426, and those with panic attacks lower SDANN 427 and higher LF power 422 than 
controls. Fibromyalgia is associated with decreased HRV, higher LF and lower HF power 428 and 
impaired circadian variation with increased LF at night 429. 
1.3.7 The relationship between HRV and cognitive performance 
In addition to being associated with health and disease, HRV shows changes associated with 
cognitive performance. However, the findings are conflicting. Subjects with high HRV have shown 
improved executive functioning including improved working memory with more correct responses 
and faster reaction times to cognitive tasks 430;431, while decreased HRV including VLF, LF and HF 
power and RMSSD has been associated with cognitive impairment 432. However, other studies show 
no relationship between HRV and cognitive impairment 433. 
In contrast, Morgan et al suggest that decreased HF power predicts improved performance 434. 
However, whilst the authors suggest that the performance measure used assessed elements of 
cognitive executive functioning, the relationship to traditional measures of performance is not 
known 434. Nevertheless, the capacity to suppress vagal tone indicates increased ability to sustain 
attention 435 and is associated with adaptive cognitive function 436 and enhanced cognitive 
performance in conditions of high stress 434. It is possible that this conflicting finding occurs when 
cognitive function is tested in stressful conditions because of the reduction in HRV caused by stress 
as described above. Supporting this idea, the Stroop task 437 which tests cognitive function and has 
been shown to induce stress effectively 438, results in decreased RR interval 439, decreased HF and LF 
HRV power and increased HR 438;440. 
1.3.8 HRV biofeedback 
Biofeedback is a process whereby different physiological parameters are displayed to the individual 
in real time. The purpose is to help them to increase awareness of their bodily processes and, 













There are many different kinds of biofeedback, including those that monitor muscle tension, skin 
conductance, EEG, EMG, temperature, heart rate and HRV. HRV biofeedback is of particular interest 
as it provides an economical, mobile and easy to use tool. HRV biofeedback could be a valuable 
method of altering autonomic activity, potentially reducing disease and improving performance. 
Different HRV biofeedback devices are available ranging from small hand held devices to larger 
devices requiring a complex setup of equipment. Hand held devices are of particular interest, as the 
intention would be to find a device that could be easily used by the individual as needed throughout 
the day. 
A typical hand held HRV biofeedback device measures the real time RR interval (Muench, 2008), and 
displays the data as an RSA wave. Using this wave, users are guided to find and maintain their 
optimal slow respiratory rates so that real-time heart rate and respiration co-varies in a perfect 
phase relationship. This occurs when one is breathing at resonance frequency of about 6 breaths per 
minute. 
1.3.8.1 Effect of HRV biofeedback on measures of HRV 
The use of HRV biofeedback does indeed result in changes in HRV. These are shown consistently in 
the short term, while long term effects are more variable 441. During HRV biofeedback, TF 442;443 and 
LF power 442-444 increase, with either no change 442;444 or a decrease 443 in HF power. In keeping with 
the increase in TF power, SDNN increases 444. In addition, a non significant increase in HR has been 
documented 444. 
Many studies have looked at the impact of HRV biofeedback on baroreflex function, as changes in 
baroreflex sensitivity could account for the increases in LF power. Most of these studies have shown 
that baroreflex gain or sensitivity increases during HRV biofeedback 443;445 or breathing at 6 breaths 
per minute 268;446, while others have shown no change 442. Wheat et al 441 suggest that the studies 
which have shown significant changes in baroreflex gain during biofeedback were methodologically 
strong while those that showed no change were not. It is thought that breathing at the resonance 
frequency  ‘exercises’  443 the baroreflex resulting in improved autonomic function 288;443. 
Increased baroreflex gain persists into the immediate post biofeedback period 443. Respiration 











it to be increased 443;444 even when respiration rate is accounted for 443, and others showing no 
change 442. No changes in HF power 442-444 are seen. 
A long-term effect has been found with increased SDNN 197;444 and LF power 444 after 4 weeks of HRV 
biofeedback. However, no changes were found in SDNN, LF, HF or TF power after 10 weeks of 
intervention 442-445;447 or at follow up 442;448. A combination of breathing, HR and HRV biofeedback for 
6 weeks resulted in increased SDNN and RMSSD after the treatment period which were still evident 
12 weeks after testing 449. Studies also have mixed results regarding baroreflex gain with some 
showing an increase 443, and others finding no long term change 442. 
1.3.8.2 Effect of HRV biofeedback in the management of disease 
Research has found HRV biofeedback to be effective in the management of anxiety, depression, 
cardiovascular disease, asthma, COPD, fibromyalgia, inflammation and insomnia.
Biofeedback has resulted in a reduction in symptoms of stress 196, anxiety 195, post traumatic stress
disorder 197 and depression 442;444 and may be effective in the treatment of major depression 444. It
seems that subjects who are able to use biofeedback more effectively have a greater reduction in
anxiety 195. Biofeedback together with psychological support 198 and in combination with Cognitive
Behavioural Therapy 199 resulted in decreased anxiety. The latter combination was found to be more 
beneficial than other relaxation techniques including meditation, yoga and unassisted breathing 199.
A few weeks of HRV biofeedback has been shown to be valuable in the management of
hypertension, heart failure and coronary artery disease. HRV biofeedback and similar slow breathing
decreased systolic blood pressure 450;451 and increased baroreflex function 451 in patients with 
hypertension, and decreased symptoms, increased exercise tolerance and increased resting oxygen
saturation in patients with heart failure 448;452;453. It also results in improved vagal heart rate
regulation in patients with coronary artery disease 196.
Increased vagal activation of the heart has been found to reduce myocardial ischemia, reperfusion-
induced arrythmias and the risk of sudden death after myocardial infarction 454;455. Therefore, 
increasing cardiac vagal modulation with HRV biofeedback may reduce the morbidity and mortality 
associated with cardiovascular disease especially diseases related to decreased vagal stimulation 











Ten weeks of HRV biofeedback has resulted in improvements in asthma including increased 
pulmonary function 445 and decreased need for controller medication 456. In addition, patients with 
COPD had an increase in RSA after treatment as well as an improvement in clinical outcome 457. 
While HRV biofeedback has not been investigated in the management of metabolic syndrome or 
diabetes, it has improved the function of the autonomic nervous system which may delay the 
progression of these diseases as well as prevent the cardiovascular complications. Finally, HRV 
biofeedback has resulted in improved symptoms and function in patients with fibromyalgia 442, 
decreased autonomic dysfunction induced by endotoxin induced inflammation 458 and an 
improvement in the quality of sleep 459. 
1.3.8.3 The effect of HRV biofeedback on cognitive performance 
Only one study has examined the effect of HRV biofeedback on cognitive performance. The authors
found a reduction in the errors made during a Stroop task. There was, however, no difference














HRV biofeedback increases cognitive performance and reduces stress and anxiety as described 
above. Examining changes in EEG provides insight into the potential mechanism of these results. EEG 
can be measured in different ways: event related potentials or phasic frequency changes are related 
to specific short term tasks 460, while tonic frequency changes occur over a longer time period 460. 
Frequency bands commonly calculated when analysing EEG include delta, theta, alpha, beta and 
gamma. While different researchers use different margins for each frequency band, delta is 
generally within 0 and 4 Hz 461-463, theta within 4 and 8 Hz 194;464-467, alpha within 7 and 14 Hz 
194;440;464;465;467-469, beta within 13 and 30 Hz 461;465;467, and gamma within 30 and 70 Hz 462;470. These 
bands can also be further divided into smaller components. Delta, theta and alpha oscillations 
generally span large cortical areas while beta and gamma are higher frequency, lower amplitude and 
distributed in more limited areas 471. 
This review focuses on the interpretation of EEG oscillations in theta, alpha and beta frequency 
bands. 
1.4.1 Interpretation of different frequency bands 
1.4.1.1 Theta 
Theta oscillations reflect changes over widespread areas of the brain including the prefrontal cortex 
472-474, anterior cingulate cortex (ACC) 475-477, neocortex 478, limbic system474;479-482, hypothalamus 474 
and brain stem 474. This allows integration of the activity in all of these locations 483. Frontal theta is 
well studied and is generated by frontal areas including the ACC 484;485, and medial and dorsolateral 
prefrontal cortex 476;486. Posterior theta is less well researched but is thought to reflect different 
functions from frontal theta 487. 
Theta oscillations in different areas are likely to have different roles 478. While theta has been related 
to a range of behavioural, cognitive and emotional variables, their main function is memory and 
emotional regulation 471. As a result of the multiple different roles, increases in theta during complex 











Frontal theta increases may be related to memory. In particular, it increases with increased working 
memory 471;475;477;490-496, with encoding and retrieval of episodic memory 477;496-506 and with the 
formation of declarative long term memory 502;507;508. In addition, theta increases with increased 
attention 473;476;477;484;486;509;510 during both mental performance and meditative concentration 477;511-
519. 
Increases in posterior theta have been linked to perceptual processing 521 as well as greater memory
based executive functions requiring visuo-motor integration 485. Two different attentional networks
have been described: an anterior network involving the detection of sensory stimuli and a posterior
network involving orienting of sensory attention 522. Posterior theta has also been found during
stage 1 sleep or hypnagogic states 521. However, while Schacter describes 2 different manifestations
of theta: a frontal midline theta related to alert states and a posterior theta which is associated with 
a hypnagogic state 521, theta found during hypnagogic states is generally spread diffusely over the
cortex 521.
1.4.1.2 Alpha 
Alpha is the dominant frequency in the scalp EEG of adult humans. It is generated mainly over
posterior brain regions 523;524 but is also found anteriorly 525. Alpha oscillations are associated with 
thalamic burst firing 526-528 and are thought to arise from cortico-thalamic 529;530 or cortico-cortical
network activity 531;532. However, the exact physiological generators of alpha are not yet known 533.
Alpha oscillations are maximal during an awake, restful state with eyes closed 534;535. They were first 
identified by Berger who found that alpha power decreased when eyes were opened 536. Alpha 
power also decreases by at least 50 % during sleep 539. 
Alpha power increases with increased internal attention 540-543 including mental calculations 544 and 
working memory demands 545;546, as well as with anticipatory waiting during attentional tasks 547. 
Increased alpha reflects active inhibition of irrelevant information, especially sensory information 
533;533;541;548-552. This provides a top down control mechanism preventing unnecessary or conflicting 
information and processes from interfering with the current internal process 460;533;533;541;548;549;553;554. 














Generally alpha and theta oscillations respond in opposite ways 471. This reciprocal relationship is 
mediated by the prefrontal cortex 471. 
1.4.1.3 Beta 
Activity in the beta frequency band is the least understood and requires much future research. Beta 
activity is thought to be related to both sensorimotor 557 and cognitive functions 467, and its main 
function appears to be the maintenance of the status quo of both motor and cognitive states 467. 
Beta activity increases during rest and, therefore, has  been  suggested  to  represent  an  ‘idling  rhythm’  
in the motor system 557. However, this may be an active rather than a passive process 467;558-561. Beta 
activity increases during steady state contractions and decreases during new voluntary movements 
562-568. Its function may be to modulate the processing of somatosensory stimuli 569 and allow 
efficient processing of feedback 562. 
Beta activity is associated with top down processing of attention 570;571. Engel et al 467 summarise the 
research and propose that beta activity increases when the current cognitive state needs to be 
actively maintained, decreases when the current state changes, and remains unchanged if there is 
no alteration to the current state. Other research, however, has found that beta activity over the 
frontal cortex was associated with decreased sustained attention 572;573. 
1.4.2 Impact of age and sex on EEG 
Both age 574 and sex 574-577 affect the average amplitude of EEG oscillations. During adulthood alpha 
578 and theta remain relatively stable 579. From the age of about 50, however,  there is a decrease in 
alpha 578 and increase in beta power 579. 
1.4.3 Effect of anxiety and relaxation on EEG 
Changes in the frequency of EEG oscillations commonly occur during anxiety and relaxation. 
Increased frontal midline theta occurs during relaxation 580-582 and relief from anxiety 194;583;584, and 
indicates lower state and trait anxiety 585. It has been positively correlated with HRV measures, 
suggesting increased parasympathetic activity 373;586;587 and negatively with an HRV index of the 











Studies examining the impact of anxiety on alpha oscillations have shown conflicting results. Some 
show that higher alpha activity is associated with lower levels of anxiety and increased feelings of 
calm and positive affect 588-590, while others indicate that alpha power is higher at baseline in anxious 
people 591;592, increases further in anxiogenic situations 591 and decreases in association with 
relaxation 580;582. An increase in alpha during anxiety may occur as a result of greater attention to the 
surrounding environment 591;593. The conflicting results most likely occur as a result of the complex 
relationship between the numerous cerebral processes that stimulate alpha oscillations. 
Feelings of anxiety have also been associated with increased beta power 594 while relaxation results 
in a decrease 582. In addition, a general increase in spectral power of all EEG bands has been 
described in response to anxiogenic situations 595. 
1.4.4 Effect of HRV biofeedback and meditation on EEG 
Very little research has been done on the effect of HRV biofeedback on EEG or even the relationship
between HRV and EEG. Thayer and Lane have proposed the Neurovisceral Integration Theory, which
describes an integrated neural network involving cognitive, affective and autonomic regulation
702;703. A key component of this system is the bidirectional central autonomic network (CAN), which
regulates HRV 702;704. Indeed,  HRV  has  been described  as  providing a  ‘structural and functional link  
between  the  brain  and  the heart’  705.
Increased HRV has been associated with increased activity in the prefrontal cortex 705;706. It has also
been associated with increased working memory and increased parasympathetic activity 704, both
processes that are related to the prefrontal cortex 706-709. Therefore, one might expect that increased 
HRV in response to biofeedback would result in increased theta oscillations, which have been 
associated with prefrontal cortex activity and related to increased working memory and increased 
parasympathetic activity. As expected, the only study on HRV biofeedback indicated that 
biofeedback resulted in increased overall theta and alpha power in the post-intervention period 596.
Much research has, however, been done on changes in EEG during meditation. HRV biofeedback can 
be viewed as a form of concentrative meditation which involves focusing on specific mental or 
sensory activities such as the breath 170. However, it is different from a concentrative meditation in 














There is large variability in the literature on EEG and meditation. However, one consistent finding is 
that power in the theta band increases during meditation 521;580;597-610. While this has most commonly 
been seen in the frontal midline areas 194;373;587;598;602;611;612, global increases in theta power have also 
been described during a yogic breath meditation 608 and in comparison to relaxation 613. Generally, 
increased theta has been associated with good technique 597;600;601;606 and long term meditation 
experience 597-599;602. 
Posterior theta is also seen during the first stage of sleep 521. However, previous research has shown 
a difference between theta associated with meditation and stage 1 sleep 597;599;600;602;606;614;615. Theta 
power during sleep typically increases globally 521. In addition, it is associated with a decrease in 
alpha power of about 50% 539, while increases in theta related to meditation are generally 
accompanied by stable or increased alpha power 608. 
While there is insufficient evidence to determine the exact cause of the pattern of theta activity 
during meditation 616, similar increases in frontal midline theta power are seen during sustained 
attention 473;476;477;486 as well as during relaxation as described above. Frontal midline theta has been 
correlated with HF HRV during meditation 373;587 suggesting increased vagal activity. 
Power in the alpha band also commonly increases during meditation 194;373;597;599;604-606;609;613;617-624, 
again largely over frontal areas 193;373;625;626, as well as during yogic breathing 187. Increased alpha 
power is also seen after meditation 622;627, and is commonly seen at rest in meditators 
597;600;601;603;606;618;619;628;629. However, not all studies have shown an increase in alpha power during 
meditation 597;630-632. Some have found an increase only in advanced practitioners 617;626, and research 
comparing meditation and relaxation has found no increase in alpha power 181;204;580;600;602;608;633. In 
addition, a decrease in alpha power over the occipital cortex has also been seen 626. 
No research has been done on beta activity during meditation. It has, however, been shown that 












1.5 SUMMARY AND CONCLUSION 
Stress is increasingly prevalent in the world today, and leads to anxiety, emotional distress and 
impaired cognitive function. Chronic psychological stress also plays an integral role in the 
development of both psychological and physical disorders, in particular, being a risk factor for 
chronic non-communicable disease. 
As the burden of stress and stress-related disease grows, it is increasingly important to identify
effective stress management techniques. While many forms of stress management are available,
many of these are lengthy, time consuming, expensive and/or require the involvement of a 
professional. Therefore, there is a need to find an effective, short duration, easily accessible method
of managing stress that is easy to use and can be self applied. HRV biofeedback shows potential as 
an effective stress management tool that fulfils these criteria.
The measurement of HRV provides a valuable quantitative marker of the effect of the autonomic
nervous system on the heart. HRV decreases in stress and anxiety, and low HRV is associated with 
many chronic diseases. While some studies show an association between decreased HRV and
impaired cognitive performance, the results are conflicting.
HRV biofeedback facilitates easy manipulation of HRV, and therefore potentially provides a valuable
intervention for altering the activity of the autonomic nervous system. HRV biofeedback increases 
HRV during biofeedback and there is some evidence that this is maintained into the immediate post
biofeedback period. However, no studies have examined changes in HRV during stress after
biofeedback.
While HRV biofeedback has been shown to lead to a reduction in symptoms of stress and anxiety, no 
studies have examined its effect on perceived relaxation states. Only one study using a 15 minute 
intervention has examined the effect of HRV biofeedback on cognitive performance, showing an 
increase in performance which was not different from the comparative intervention. 
Changes in EEG are evident in anxiety, as well as during relaxation and meditation. Only one other 
study has examined the effect of HRV biofeedback on EEG in the immediate post biofeedback 













EEG during and after HRV biofeedback may contribute to understanding the mechanisms 
contributing to the reduction in anxiety and improved performance that has been shown. 
The majority of studies on HRV biofeedback focus primarily on clinical outcomes and, therefore, the 
long-term effect of HRV biofeedback over sessions, rather than the acute effects. Furthermore, most 
use the conventional training protocol as described by Lehrer et al 634. We were specifically 
interested in the acute effect of 10 minutes of biofeedback, as this is the period recommended by 
the manufacturer for clinical use. The minimum recommended time per session is 5 minutes with a 












1.6 OBJECTIVES OF THE THESIS 
Therefore, the objective of this thesis is to examine the effects of a single 10 minute episode of HRV 
biofeedback on measures of HRV and EEG during and immediately after the intervention, measures 
of HRV and cognitive performance during laboratory induced cognitive stress and subjective feelings 
of anxiety and relaxation states after testing. 
The general methodology used is described in Chapter 2. Chapter 3 describes the changes in
cognitive performance. Changes in measures of HRV are detailed in Chapter 4 and changes in EEG in
Chapter 5, while Chapter 6 describes the changes in measures of anxiety and relaxation states.
Finally, Chapter 7 concludes with a summary and clinical interpretation of the results, a description
of the clinical application of HRV biofeedback as well as a description of the limitations of this study














Eighteen male volunteers (34 ± 6 years) who were employed in senior managerial positions were 
recruited for this study. To be included, volunteers had to have been exposed to work related stress 
and to have subjectively rated their own perception of life stress as high. Their trait anxiety was 
measured using the trait component of a Spielberger State-Trait Anxiety Inventory (STAIT) 636 which 
they completed online. Subjects were screened via email. On arrival before the training session a 
brief history was taken by a medical doctor, to confirm the responses. 
A previous clinical diagnosis of anxiety-related disorders disqualified participation in the study.
Further exclusion criteria included: previously diagnosed cardiac or psychiatric disorders, current use
of psychotropic or heart rate altering medications or current use of stimulants or recreational drugs,
as well as volunteers practicing regular meditation techniques. Volunteers were asked about their
exercise practices as well as breathing and meditation practices as these would have had the
greatest impact on the outcome of the intervention. Volunteers who were technically unable to use
the biofeedback device or perform the modified Stroop task were excluded from the trial. This 
applied to 2 subjects, one of whom had chronic low circulation and so the device was unable to
obtain a clear pulse reading. The other subject was excluded as, on completion of the familiarization
Stroop task, he still did not understand what to do, and continued to confuse the response keys and,
therefore, could not respond effectively. We elected to test only men in an attempt to limit
heterogeneity because men and women respond differently to different psychological stressors 48;53
with varied HPA axis responses 46;48 as well as neural responses 637 to stress.
Subjects were randomly assigned to either an HRV biofeedback (BIO) group or a comparative (COM) 
group using a process of stratified randomization. The initial group of subjects was matched into two 
groups based on age and thereafter subjects were randomly assigned to either group. Each group 
consisted of 9 subjects. We decided to use a single intervention and comparative group design, as a 
crossover design may have confounded the interpretation in the event of there being any carry over 











The study protocol was approved by the Research and Ethics Committee of the University of Cape 
Town (Rec ref: 296/2005) in accordance with the Declaration of Helsinki. All subjects signed 
informed consent prior to participation in the study. 
2.2 TRAINING AND FAMILIARIZATION PROTOCOL 
Volunteers were instructed not to eat a heavy meal, ingest caffeine or alcohol, or exercise within 4 
hours before arriving at the laboratory. Compliance was checked before the onset of each testing 
session. 
All subjects underwent a single standardised training session during the week prior to the start of
their experimental trials. On arrival, height was measured using a Leicester 214 Portable
Stadiometer (Lifemax) and weight was measured using a TCS-A 300 kg Platform Scale (Clover Scales).
Body mass index (BMI) was calculated using the formula BMI = weight (kg)/ height (m)2 638.
A hand-held mobile  HRV  biofeedback  device  (StressEraser™,  Helicor,  USA)  validated by Heilman et al
639 was used for both the training and the testing sessions in the BIO group. An infrared emitter and
sensor incorporated into the device into which the subject placed their index finger, measured the
real-time interbeat-interval (IBI) of the heart using finger photoplethysmography 635. The IBI data are 
transformed and displayed as a wave on a LCD screen, allowing users to see the real-time
fluctuations of their pulse rates. This wave reflects respiratory sinus arrythmia (RSA), which is the
cyclical change in heart rate occurring in response to respiration. Using the RSA wave, users are
guided to find their optimal slow respiration rate and to maintain a cognitive focus so that real-time
heart rate and respiration co-varies in a perfect phase relationship. To achieve this, the subjects
were instructed to inhale until the RSA wave reached its peak and exhale until the wave started to
rise again. They were taught pursed-lips abdominal breathing and were instructed to relax and
breathe comfortably without straining 634.
The device rewards users with points based on the wavelength for each RSA cycle. If the wavelength 
meets a certain threshold (10 seconds), users are given 1 point marked by three vertical squares. 
Two vertical squares receive .5 point and one vertical square receives no credit. The goal is to 
accumulate continuous points during the session. To assist users in obtaining points, the device 











of the wave indicates the moment heart rate deceleration is to begin, indicating the 
parasympathetic response. Users were instructed to begin their exhalation when the triangle 
appears. They were instructed to extend their exhalation for as long as possible until the wave 
begins to rise again. Although the device offers points based on RSA wavelength, users were 
instructed to maximize RSA amplitude simply by following the RSA wave (e.g. inhale until the wave 
stopped rising and exhale until the wave stops falling). While this device does not, technically, 
facilitate resonance frequency breathing as time domain analysis was used rather than frequency 
analysis; it does functionally facilitate a similar breathing frequency. 
There is a risk of adverse first session effects with a single training session of HRV biofeedback,
however these may be decreased with the use of pursed-lips breathing 634. Subjects are not familiar
with the technique and so may have difficulty performing it, causing possible anxiety 199;288. In
addition, there may be a tendency to hyperventilate 288;640 resulting in dizziness. Only 1 out of the 9
subjects reported difficulty performing the technique during training, and no subjects reported
dizziness or other adverse effects.
The device used in the COM group was also manufactured by Helicor (USA). It appeared identical to
the BIO device, but made use of a different algorithm to display a wave on the screen. The algorithm
that  generated  this  wave  was  derived  from the  subject’s  heart  rate  measured by the  sensor,  divided
by 2 plus a random number which ranged between 0 and 25 % of the heart rate/2 value. This result
was then smoothed by averaging the calculation over 5 seconds. Subjects were informed that the
wave represented their blood density and were instructed to watch the wave whilst not thinking any
stressful thoughts. They were not instructed to alter the wave in any way.
All of the subjects were told that we were comparing the effect of 2 different devices on laboratory 
induced cognitive stress; therefore both groups were given the impression that their device worked. 
Both groups had devices that appeared identical and both were instructed to observe the wave that 
appeared on the screen of the device. The only difference in instructions was that the BIO group 
were instructed to alter their breathing in response to the wave, while the COM group were 
instructed to observe the wave whilst not thinking stressful thoughts. While the BIO group focused 











After subjects had received their respective instruction, they completed a formal 10 min biofeedback 
session with either the BIO or COM device and their scores were recorded.  A score of 30 or more on 
the BIO device was indicative of a successful session. 
2.3 EXPERIMENTAL TRIAL 
The time line for the experimental trial is shown in Figure 2.1 below. On arrival at the laboratory,
subjects completed the state component of a Spielberger State-Trait Anxiety Inventory (STAIS) 636
and the Smith Relaxation States Inventory 3 (SRSI3) 641 and were reminded how to use their
respective devices. Subjects then underwent a full familiarization modified Stroop task lasting 5
minutes and 24 seconds. After the familiarisation test, electrodes and transducers were applied to
the subjects and connected to a Biopac MP150WSW (Biopac Systems, Goleta, CA, USA) to record
electrocardiogram (ECG), respiratory rate and electroencephalogram (EEG). The Biopac MP system is
a laboratory based physiological monitoring system which is commonly used as a research tool, and
has been cited in numerous publications 639. Subjects were seat d throughout the testing and were
instructed to move as little as possible. Leads were taped down to prevent interference.
Subjects were then instructed to relax with their eyes closed for 5 minutes (Rest 1) during which 
time measurements of baseline ECG, respiratory rate and EEG were recorded. Immediately after the 
PREP 
START R1 S1 INTERVENTION  R2 S2 FINISH
Questionnaires completed 
Comparative intervention 
Modified Stroop task  
Preparation 
Rest period  
 HRV Biofeedback Intervention  PREP
Figure 2.1 Diagram depicting the time line of the trial protocol on the day of final testing 
HRV = heart rate variability; R1 = First rest period; S1= First Stroop task; R2 = Second rest period; S2 = 













baseline period and without moving, subjects were instructed to open their eyes and complete the 
pre-intervention Stroop task (Stroop 1) which lasted 5 min 24 s in duration. Subjects then completed 
a 10 minute intervention with either the BIO or COM device. After the intervention, subjects 
completed a further 5 minute rest period (Rest 2) with their eyes closed before completing a post-
intervention Stroop task (Stroop 2). ECG, respiratory rate and EEG were recorded throughout the 
testing. 
After the final measurements, subjects completed post-testing STAIS and SRSI3 questionnaires. In 
addition, subjects were asked to rate the subjective efficacy of the intervention as well as feelings of 
sleepiness using a visual analogue scale (VAS) devised for this study. In response to each question, 
subjects   scored   from   1   to   10   with   1   being   ‘not   at   all’   and   10   being   ‘extremely’   with   regard   to  
helpfulness and sleepiness. 
2.3.1 Modified Stroop Task 
We modified the original Stroop task 437 by computerising so that subjects responded by pressing 
keypad buttons instead of responding verbally. In addition, we added a working memory 
component. The colour word component was previously validated by Rauch et al 642 as follows. 
Twelve female subjects (students aged 18 - 25) repeated a Stroop task of about 5 minutes duration 
which consisted of only incongruent cues. Each task contained 72 colour words with each word 
being displayed for 400 ms followed by a 3.5 s response time. Five tasks were repeated one after 
another with a 1 min break in between each Task. Between 7 and 10 days later the subjects 
repeated the 5 x 5 min Stroop tasks at the same time of day (day 2). 
In the current study, the modified Stroop task entailed the individual presentation of cues (2 cm in 
height) in the centre of a computer monitor on a black background.  Cues consisted of colour-words 
(red, blue, green and yellow) and single white squares. Cues appeared every 3 seconds and were 
displayed for 400 ms after which they were replaced by a black screen which lasted for 2600 ms and 
which constituted the response period.  The 4 colour-words were presented in 5 different colour 
inks: red, blue, green, yellow and grey.  The colour words were either presented in grey ink or in a 
colour ink incongruent with the meaning of the word, i.e. red in blue colour, or green in yellow 
colour, but never red in red colour or blue in blue colour, etc. The subjects were asked to respond as 
quickly and as accurately as possible by pressing one of four response buttons to indicate either the 











in grey ink). Subjects were not required to respond to the white squares other than counting the 
cumulative total number of squares throughout the test. They were instructed to report the total 
number of squares at the end of each Stroop task. This value was compared between Stroop 1 and 
2. They were not told how many squares there were in the test, only that they were randomly
generated. Counting squares tests the updating of working memory, while responding to the colour
words tests inhibition of prepotent responses together with the delicate balancing of the speed-
accuracy trade-off 643.
Subjects used the index and middle fingers of each hand to press the response buttons (1 for red and 
2 for blue with the left hand and 7 for green and 8 for yellow with the right hand) on an 8 button 
response box. 
In total, 108 cues were randomly presented: 18 incongruent colour words in each of the 4 colours
(72 incongruent words in total), 18 grey words and 18 white squares. The use of the grey words
ensured that subjects had to read and recognize the colour words rather than just noticing the
colours, thereby invoking the Stroop effect 437.
2.3.2 Questionnaires used 
Validated questionnaires were used to assess anxiety and relaxation states as this has been shown to
increase the reliability of self-reported data 644. State anxiety was assessed using the state 
component of the Spielberger State-Trait Anxiety Inventory (STAIS) and trait anxiety using the trait
component (STAIT) 636. Each component consists of 20 self-report items measured using a 4-point
Likert  scale  ranging from 1 (‘not  at  all’)  to 4 (‘very much  so’).  This  yields  a  total score  which ranges
from 20 to 80 points. The STAIT/S is a commonly used measure of anxiety 645 which shows good
internal consistency and test-retest reliability across populations 646.
Relaxation states were measured using the Smith Relaxation States Inventory 3 (SRSI3) 641. This 
consists of 38 self-report items measured using a 6-point Likert scale ranging from 1  (‘not  at  all’)  to  6  
(‘maximum’),  which  are  combined   into  19  relaxation  states  each  with  a  maximum  score  of  6.  This  
yields a total relaxation states score which can range from 19 to 114. The 19 relaxation states are 
divided into 4 categories loosely based on factor analytic research 647. The categories consist of 
mindfulness, energized positive feelings, basic relaxation and transcendence. Reliability for the SRSI3 











(excluding the 3 new subcategories of mindful acceptance, mindful centering and mindful 
awakening) has been shown to be reliable 206. 
2.3.3 Data recording 
ECG activity was recorded from 3 electrodes (Blue Sensor, Ambu, Denmark) placed in positions
representing Eindhoven’s triangle: namely, sub-clavicular bilaterally and over the left anterior 
superior iliac crest. The skin surface was cleaned and gently abraded with an alcohol swab before
electrodes were attached. Electrode cables were taped down to prevent movement artefact. ECG
electrodes were connected to the Biopac ECG amplifier set to band-pass filter between 0.5 and 35
Hz (Biopac Inc. Application Note 233) and a sampling frequency of 1000 Hz. ECG recordings were
analysed with AcqKnowledge for Macintosh OS X (version 3.9.0). This software used a modified Pan
and Tompkins algorithm to detect QRS complexes. The filtered ECG recording tachograms were
then visually inspected to determine the correct recognition of QRS complexes. Missed and ectopic
beats were corrected by either adding or spacing beats. This procedure was only necessary in 2 of 
the 90 ECG recordings and only affected a total of 5 heart beats.
Only after each tachogram showed no spurious beats were the data analysed using HRV analysis 
software from the Biomedical Signal Analysis Group (Department of Applied Physics, University of
Kuopio, Finland). RR interval data were transformed using Fast Fourier Transform to calculate
components of spectral power within the low frequency (LF; 0.04 - 0.15 Hz), high frequency (HF; 0.15
- 0.4 Hz) and total frequency (TF; 0.005 – 0.4 Hz) bands 15;228. In addition, the program generated
time-domain variables including mean HR, SDNN and RMSSD. The HRV power spectrum analysis
during the intervention was conducted from minute 1 to minute 6 of the 10 minute session. This 
provided a 5 minute period as the standard time period of comparison in keeping with the 
recommendation that the optimal length of recording for short-term recordings is 5 minutes 15.
The respiratory rate per minute was measured via a force transducer fixed to a belt placed around 
the chest wall.  Subjects were asked to expel the air from their lungs when the transducer belt was 
first fitted and then instructed to breathe normally.  The chest transducer was connected to an 
amplifier with a low-pass 10 Hz filter.  Respiratory frequencies (RF), i.e. breaths per second, were 













EEG was recorded from electrodes at Fp1, Fp2, Fz, Cz and Pz. A linked earlobe reference was used. 
EEG electrodes were connected to the Biopac EEG amplifier set to band-pass filter between 0.1 and 
100 Hz and a sampling frequency of 500 Hz. EEG recordings were analysed with AcqKnowledge 
(Version 4.2). While EMG was not recorded, FFT of the raw data showed no peaks greater than 40 Hz 
suggesting that there were no large muscle contractions. Data were FIR band pass filtered using a 
Hamming window with a low frequency cut-off of 0.5 Hz, a high frequency cut-off of 30 Hz and the 
number of coefficients fixed at 4000. Eye blink/movement artefacts were identified using Fp1 and 
Fp2 648;649 and the artefact-scored segments were eliminated from subsequent analysis. In addition, 
any segments containing voltages greater than 75 µV were rejected as artefacts and excluded as 
they were likely caused by spurious muscle contraction or artefact noise. 
Data were excluded from two subjects, one from each group, for the duratio  of the testing, and 
from one subject from the COM group, for the intervention, as the sample lengths after artefact 
rejection were too short to accurately measure power in the frequency bands, and a sample size of 
at least 120 ms is required to measure alpha power accurately 575. In addition, the Pz electrode in the 
data from one subject in each group malfunctioned. 
Data were fast Fourier transformed using a Hamming window. Power spectral density (µV2/Hz) in 
the  theta  (θ,  4  – 7 Hz), alpha  (α,  7  – 14  Hz)  and  beta  (β,  15  – 30 Hz) frequency bands 465;477;650 were 
extracted using a Matlab program (Matlab, Mathworks, Version 7.11.0.584 (R2010b)) specifically 
designed for this process. There are many methods of calculating power. The calculation of power 
spectral density involves normalizing the data which yields absolute power values that may be lower 
than those found with other calculations. Relative power was calculated as it gives a better estimate 
of the dominant frequency changes 460 as well as eliminating individual variations 651. It was 
calculated by dividing the absolute power in each band by the total power across all 3 bands and 












2.4 STATISTICAL ANALYSIS 
2.4.1 Subject characteristics 
A comparison of subject characteristics between groups was analysed using an independent t – test. 
2.4.2 Cognitive performance  
Differences in reaction time between Stroop 1 and 2 were analysed using repeated measures 
analysis of variance. Specifically, differences in the main effects (group and time) and the interaction 
of  group  X  time  were  determined.  A  Tukey’s  post hoc test was used to determine specific differences 
in the event of there being a significant main effect or interaction. 
An independent t – test was used to analyse the percentage improvement in reaction time and
percentage improvement in standard deviation of reaction time between Stroop 1 and 2. This last 
analysis was done in view of the wide range of standard deviation as a result of the different
responses to different colours. This is an important finding and so it has been included; however, it is 
important to interpret the percentage improvement results with caution at the risk of making a type
1 error.
Levene’s test   of   homogeneity revealed that the mistakes made   in responding to cues during the
Stroop task were of unequal variance, and thus non-parametric tests were used to determine
differences  with  respect  to the  outcome  measures.  Accordingly  the  Friedman’s  analysis  of  variance
for repeated measures was used to determine differences in values between tests. A Wilcoxon test
was used to locate the specific differences when the overall value was significant and a Mann-
Whitney test was used to compare values between groups.
2.4.3 HRV and respiratory data 
As   the   sample   size   was   relatively   small   and   Levene’s   test   of   homogeneity   revealed   that   the  
respiratory data and HRV measures were of unequal variance, non-parametric tests were used to 
determine differences with respect to the outcome measures. These have been described above in 













Data from during the intervention and during the rest periods were analysed separately, as the 
subject’s  eyes  were  closed  during   the   rest  periods  and open during the intervention which would 
have altered the alpha power 537;538 thus making comparisons misleading. 
During the intervention, the comparison of absolute power, relative power and theta/beta ratios 
between groups were analysed using an independent t-test. Differences between relative power and 
theta/beta ratios during Rest 1 and Rest 2 were analysed using repeated measures analysis of 
variance (ANOVA). Specifically, differences in the main effects (group and time) and the interaction 
of  group  X  time  were  determined.  A  Tukey’s  post hoc test was used to determine specific differences 
in the event of there being a significant main or interaction effect. 
Levene’s   test   of   homogeneity revealed   that   the   absolute power   during Rest 1 and Rest 2 was of
unequal variance; therefore non-parametric tests were used to determine differences with respect
to the outcome measures. These have been described above in 2.4.2.
The relationships between the BIO intervention scores and measures of relative EEG and theta/beta
ratios were determined  by calculating Pearson’s  correlation coefficients.  The  relationships  between
BIO intervention scores and absolute EEG, between measures of EEG and measures of HRV, and
between measures of EEG and respiratory frequency were determined by calculating Spearman’s  
rank order correlation coefficients.
2.4.5 Questionnaires 
Comparisons of STAIT and VAS scores between groups were analysed using an independent t – test. 
Differences in STAIS and SRSI3 scores between groups were analysed using repeated measures 
analysis of variance (ANOVA). Specifically, differences in the main effects (group and time) and the 
interaction  of  group  X  time  were  determined.  A  Tukey’s  post hoc test was used to determine specific 
differences in the event of there being a significant interaction effect. 
Cohen’s  d effect sizes 652 were calculated on the STAIS, SRSI3 total scores and scores for the 4 major 
SRSI3 categories. Effect sizes were calculated using the formula d = mean (a) – mean (b)/ (pooled 











having a moderate effect and 0.8 or greater as having a large effect 652. Effect sizes of 0.5 or greater 
were regarded as meaningful. 
Relationships between variability in the STAIT questionnaire and pre-testing STAIS questionnaire, as 
well as between changes in the STAIS and changes in SRSI3 scores, were determined by calculating 
the Pearson’s correlation coefficients. 
2.4.6 General 
All parametric data are described as mean  standard deviation (SD) and non-parametric data as
median and interquartile range (IQR). Correlations are expressed as r with the 95% confidence
interval. A P value of < 0.05 was considered to be statistically significant. P values greater than 0.05












THE EFFECT OF A SINGLE SESSION OF SHORT DURATION HRV 
BIOFEEDBACK ON COGNITIVE PERFORMANCE DURING 
LABORATORY INDUCED COGNITIVE STRESS 
3.1 INTRODUCTION 
Cognitive performance is affected by adverse psychological stress, potentially leading to decreased
productivity. Chronic psychological stress leads to impaired general cognitive function 130;131;144
specifically including impaired set shifting 146. Both acute 133 and chronic 157 stress result in impaired
memory related to an increase in plasma cortisol concentrations 130;131;140. Stress impairs working
memory linked to high cortisol concentrations 145 and has also been associated with greater error-
related brain activity 151.
Adverse chronic psychological stress also induces states of low HRV 336;352;359;360. While greater HRV
has been associated with increased executive functioning including faster reaction times and more
correct responses to cognitive tasks 430;431. The finding that increased HRV may be associated with 
improved cognitive performance, illustrates the importance of techniques which could counter the
vagal lowering effects of chronic stress.
HRV biofeedback has been shown to increase HRV both during the intervention 442-444 and
immediately after the intervention 443;444, as well as decrease perceived stress 196. Only one study has
examined the effect of HRV biofeedback on cognitive performance. The authors found a reduction in
the errors made during a Stroop task, however, there was no difference between the HRV
biofeedback group and a non-biofeedback concentrative control group 195. Therefore, the aim of this
chapter was to examine the acute effect of 10 minutes of HRV biofeedback on cognitive












The methodology for this chapter can be found in Chapter 2 . General methodology is described on 
pages 35 to 39, methodology regarding the modified Stroop task on pages 39 and 40, and statistics 
specific to cognitive performance on pages 43 and 45. 
3.3 RESULTS 
3.3.1 Subject characteristics 
All subjects were employed at a senior to executive management level and had significant 
responsibility in terms of managing finances, people and/or projects. The exact nature of each job
was different for each person, however, all were related to information systems, health and
wellness, engineering or banking. All subjects were healthy and were not using psychotropic or heart
rate altering medications, stimulants or recreational drugs.
The BIO and COM groups were similar in age (33 ± 6 vs. 34 ± 6 years respectively), body mass index
(28.7 ± 6.8 vs. 27.2 ± 4.5 kg/m², respectively) and adherence to exercise training (3 ± 1 vs. 3 ± 1 units
respectively) measured on a scale of 1 to 5 (1 = less than once a month, 5 = every day). There was no
difference between groups in the STAIT questionnaire (48 ± 6 vs. 44 ± 7 units, BIO vs. COM).
3.3.2 Cognitive performance
Subjects were instructed to respond as fast and as accurately as possible. During any decision
making task, subjects have to balance speed with accuracy (known as the speed-accuracy trade-off)
and studies have shown that when subjects focus more on responding as fast as possible they make 
more mistakes, thereby sacrificing accuracy for speed 642;653.
The data from one subject in the COM group was excluded as the mistakes that he made during 
Stroop 2 were more than 3 standard deviations greater than the mean while all of the other subjects 
were within 1 standard deviation. Furthermore, he increased his reaction time more than any other 
subject and in response to some colours more than 2 standard deviations from the mean. This 
suggests that he was not as focused on minimising mistakes as the other subjects were, and thus 











changes in reaction time would have an impact on changes in his accuracy, since subjects balance 
speed and accuracy 643. The data from 2 other subjects (one from each group) were missing as a 
result of failure of the recording equipment. 
3.3.2.1 Mistakes made 
A detailed analysis of the mistakes made by the subjects in the BIO and COM groups during the 
modified Stroop tasks before and after intervention is shown in Figure 3.1 below. 
Figure 3.1 The percentage of correct responses to squares cues (a), word cues (b) and total cues (c) 
during the first and second modified Stroop tasks in the BIO and COM groups 
BIO, biofeedback group; COM, comparative group 











There were no differences in the total mistakes made in either group in identifying the 108 cues over 
time. By differentiating the mistakes made on identification of colour words from the mistakes made 
while counting the total number of squares it was determined that word mistakes were not 
significantly different pre- vs. post-intervention in either group. However, there was a significant 
difference in mistakes made in responding to squares. After the intervention no subject in the BIO 
group missed any squares (1 ± 1 vs. 0 squares missed, Stroop 1 vs. Stroop 2, p < 0.05), while subjects 
in the COM group missed as many squares after the intervention as they did before (1 ± 1 vs. 0 ± 1 
squares missed, Stroop 1 vs. Stroop 2). 
3.3.2.2 Reaction time 
ANOVA showed a time effect with improved reaction time to all colours (BIO group: 1.16 ± 0.15 s vs.
0.98 ± 0.13 s, pre vs. post; COM group: 1.25 ± 0.20 s vs. 1.19 ± 0.23 s, pre vs. post; p < 0.01) and to
grey colours (BIO group: 1.30 ± 0.21 s vs. 1.14 ± 0.21 s, pre vs. post; COM group: 1.26 ± 0.17 s vs.
1.27 ± 0.23 s, pre vs. post; p < 0.05), as well as an interaction effect with the BIO group improving
more than the COM group in response to grey colours (p <0.05). Tukey’s  post hoc test showed a 
decrease in reaction time in response to grey colours in the BIO group from Stroop 1 to Stroop 2
(p<0.05). There was no group effect.
Figure 3.2 below shows each subject’s average percentage improvement in reaction time to all
colours and Figure 3.3 below shows each subject’s average percentage improvement in reaction
time to grey colours. When looking at the percentage improvement in reaction time, the BIO group
improved significantly more than the COM group when responding to grey colours (p < 0.05) as well
as to all colours (p < 0.05). It is interesting to note that all 8 of the BIO subjects improved their
reaction time to all colours by more than 5%, while only 3 of the COM subjects improved their











Figure 3.2 Individual subject’s average percentage improvement   in reaction time   to all colours
during the first and second modified Stroop tasks in the BIO and COM groups
BIO, biofeedback group; COM, comparative group 
# P<0.05 BIO mean percentage improvement in reaction time vs. COM mean percentage improvement in reaction
time 
Figure 3.3 Individual  subject’s  average  percentage  improvement   in  reaction  time  to  grey  colours  
during the first and second modified Stroop tasks in the BIO and COM groups 
BIO, biofeedback group; COM, comparative group 












Figure 3.4 below shows the percentage change in the standard deviation of the reaction time 
between Stroop 1 and Stroop 2. The BIO group significantly decreased the standard deviation of 
their reaction times to all colours compared to the COM group (p < 0.05). Furthermore, 7 of the BIO 
subjects had tighter standard deviation values in their reaction times compared to only 2 of the COM 
group. 
Figure 3.4 Individual subject’s average percentage change in the standard deviation of   their
reaction time to all colours during the first and second modified Stroop tasks in the BIO and COM
groups
BIO, biofeedback group; COM, comparative group
# P<0.05 BIO mean percentage change in the standard deviation of reaction time vs. COM mean percentage












The key finding in this study was that the use of a short duration HRV biofeedback intervention 
resulted in improved cognitive performance during a modified Stroop task. This effect was not seen 
after the comparative intervention. Improvements in cognitive performance were evidenced by 
increased speed and consistency of reaction times after the intervention as well as fewer mistakes 
made in counting the number of square cues. 
Factors influencing cognitive performance and mistakes made are complex. The modified Stroop
task provided a complex cognitive challenge which included 3 elements of executive functioning:
updating of working memory, mental set shifting and inhibition of prepotent responses 654. Counting
squares entails updating information in working memory, mental set shifting occurs when subjects
shift from counting squares to responding to the colour words and inhibition of prepotent responses
occurs when subjects react to the colour rather than to the word.
Both groups improved their reaction time from Stroop 1 to Stroop 2. This improvement is unlikely to
be due to the learning effect of the Stroop task, as a previously completed validation trial showed a
learning effect between the first and second modified Stroop task but not between the second and
third 642. For this reason we used a familiarisation Stroop task as the first task. Furthermore, ANOVA
showed that the BIO group improved significantly more than the COM group, reinforcing that this
improvement did not result from a learning effect.
The standard deviation of the reaction time to cues in the BIO group decreased after the 
intervention while the standard deviation of the COM group increased. This shows that the BIO 
group were more consistent in their responses during the Stroop task after the intervention 
compared to before the intervention. 
While there were no differences in mistakes made in responding to words in either group, there 
were differences in the mistakes made in counting squares. None of the BIO subjects missed any of 
the squares after the intervention resulting in a significant improvement; however, the COM 
subjects missed as many squares after the intervention as before. This strongly suggests working 











cognitive performance suggest that the BIO subjects were more focused, while the COM subjects 
may have allowed their attention to wander somewhat more. 
There is a balance between speed and accuracy when responding to a Stroop task 642;653. In a 
previous validation trial Rauch et al 642 showed that some subjects were more intent on obtaining a 
faster reaction time while others seemed to be more concerned with accuracy and so sacrificed 
speed. This resulted in an inverse relationship between reaction time and number of mistakes made. 
Subjects were consistent in the number of mistakes that they made – whether high or low - in 
response to a modified Stroop task on 2 separate days. These subjects could generally tell how many 
mistakes they made, but they did not have a clear idea about their reaction time (unpublished 
observations). 
In this regard, Mayes and co-workers found that 7 – 9 year old children, who were cocaine exposed
prenatally, reacted significantly slower than non-drug-exposed matched controls during a Stroop
task; however, they did not make more mistakes in responding to the colour words (2% vs. 3%).
Thus, even though the cortical processing speed of the cocaine exposed children was impaired, they
merely slowed their reaction time to keep their mistakes in line with controls 655.
This study also demonstrated that the mistakes made in responding to colour words were in the 
range of 1 – 3 %. While most of the subjects increased their reaction time in the post-intervention
Stroop task (except for 2 COM subjects), they made a similar amount of mistakes in responding to
words. This suggests that there is a range of mistakes, remarkably similar throughout the above
studies, that subjects are comfortable with, and that they adjust their reaction times to
accommodate this range. However, it is important to note that the subjects in the BIO group
decreased their reaction time more than the COM group, while not increasing the amounts of
mistakes made, indicating improved cognitive performance.
The increased cognitive performance evident after HRV biofeedback may be related to improved 
HRV together with changes in EEG. HRV biofeedback resulted in increased HRV, which has been 
shown to lead to improved cognitive performance 430;431. Thayer and Lane describe a neurovisceral 
integration theory, in which HRV influences neural structures which impact cognitive performance 
702;703. Increasing HRV would therefore lead to improved performance 706. While both groups 
experienced vagal withdrawal in response to stress, the patterns of vagal modulation in each group 











cognitive  performance  between  groups.  According  to  Porges’  polyvagal  theory,  the  pattern  of  vagal  
withdrawal evident in the BIO group would allow effective social engagement in a stressful 
environment, which increases the ability to function successfully and perform well 319;324. These 
results are described and discussed in full in Chapter 4. 
EEG changes during and after HRV biofeedback were suggestive of increased attention together with 
increased relaxation (described in Chapter 5). It is possible that increased attention led to the 
improved cognitive performance seen in the BIO group. Finally, the BIO group felt alert and relaxed, 
and had greater increases in mindfulness and energized positive feelings (results described in 
Chapter 6). Increased mindfulness has been associated with a state of relaxed alertness 200, and both 
mindfulness and positive emotions are associated with improved attention and cognitive 
performance 675-677;683;684. 
It is of interest to note that the above cognitive improvements were witnessed after only a 10
minute intervention. We were specifically interested in the acute effect of 10 minutes of
biofeedback, as this is the period recommended for clinical use. The minimum recommended time
per session is 5 minutes with a goal to accumulate a total of 20 minutes per day 635. The intention is
to create a device that could be used easily for short periods of time as needed throughout the day.
Importantly, the results of this study perhaps fail to reflect the magnitude of the effect which might
become evident with a longer duration intervention or indeed regular training with the intervention.
3.5 CONCLUSION
In conclusion, the use of a short duration HRV biofeedback intervention resulted in improved 
cognitive performance. Reaction time was improved and more consistent, and there was a reduction 
in mistakes made in counting squares during a modified Stroop task. 
Chapter 4 will evaluate the changes in HRV that occur during HRV biofeedback, in the immediate 
post-biofeedback period and during the Stroop task. This provides insight into underlying 












THE EFFECT OF A SINGLE SESSION OF SHORT DURATION HRV 
BIOFEEDBACK ON MEASURES OF HRV DURING LABORATORY 
INDUCED COGNITIVE STRESS 
4.1 INTRODUCTION 
Autonomic nervous system modulation during stress and its effect on health and disease has
recently been a topic of much debate. Occupational (work related) stress decreases HRV 212;336;352
and is associated with increased risk of chronic disease 92;656 as well as impaired cognitive function
130;144. The previous chapter demonstrated that the use of HRV biofeedback-induced breathing at 0.1
Hz resulted in improved cognitive performance. There is a strong link between changes in measures
of HRV and changes in cognitive performance, with high HRV correlating with improved executive
functioning 430;431. Furthermore, HRV biofeedback has been shown to reduce stress and anxiety
196;199.
HRV biofeedback guides the user to breathe at the optimal respiratory frequency to maximally
increase their HRV. During HRV biofeedback there is an acute increase in baroreflex gain 443;445, SDNN
444, and TF 442-445 and LF power 442-445;456 in the cardiac spectrogram, indicative of increased vagal
modulation of the heart 443;444.
The majority of studies focus primarily on clinical outcomes and, therefore, the long term effect of
HRV biofeedback over sessions, rather than the acute effects. The few studies that have examined
the short-term carry-over effect showed that the increased vagal stimulation of the heart seen
during biofeedback persisted into the period immediately following the biofeedback as evidenced by
an increase in SDNN 444, LF power 444 and baroreflex gain 442;443. No studies have examined changes in
HRV during stress after biofeedback.
Therefore, the aim of this chapter is to examine the acute effect of 10 minutes of HRV biofeedback 
on measures of HRV during the use of the intervention, in the immediate post-biofeedback period 














The methodology for this chapter can be found in Chapter 2 . General methodology is described on 
pages 35 to 39, methodology regarding the measurement and analysis of HRV and respiration on 
page 41, and statistics specific to analysis of HRV and respiration on pages 43 and 45. 
4.3 RESULTS AND DISCUSSION 
The novel finding of this study is the presence of a short-term carry-over effect after HRV 
biofeedback that modified the physiological response during both the 5 min rest period and the 
following 5 min laboratory induced stress. This effect was evidenced by an unchanged heart rate, 
RMSSD and HF power in Stroop 2 relative to the preceding rest period, indicative of maintained HF 
vagal control of the heart and concurrent LF vagal withdrawal when shifting from rest to stress. 
HRV data during Rest 1 were compared with normative data described by Nunan et al 710. The SDNN, 
RMSSD and absolute HF power data were within the normal range and medians were similar to the 
medians described 710. The median of the LF data was just outside the upper limit of the normative 
data. A potential explanation could be that the subjects experienced psychological stress related to 
the upcoming Stroop task which led to an increase in LF power 212;225;352;359. 
4.3.1 Normal response to stress 
When an individual is exposed to acute stress the sympathetic nervous system becomes more active 
657. Respiratory rate 658 and heart rate increase 352;368, and LF power 212, HF power 352;356, SDNN 352 and 
RMSSD 353 decrease. 
The findings of this study were in accordance with these physiological changes. During Rest 1 prior to 
the first Stroop task, while RF was lower in the BIO group than the COM group (p<0.05), there were 
no differences in HR or any of the measures of HRV. During the first Stroop task there were no 
differences between groups and both groups responded similarly to stress: respiratory frequency 
(BIO p<0.05, COM p<0.01) and heart rate (BIO p<0.05, COM p<0.05) increased, and TF (BIO p<0.05, 
COM p<0.05) and LF power (BIO p<0.05, COM p<0.05) decreased. HF power decreased in both 
groups with the BIO group attaining statistical significance (BIO p<0.05, COM p=0.08), and RMSSD 











SDNN reflects all cyclic components responsible for the variability  during the recording 15, therefore 
as TF power decreased one would have expected SDNN to decrease. While SDNN did decrease in 
both groups, this decrease did not reach significance due to the large inter-subject variability. These 
results are shown in the first 2 data columns of Table 4.1, and the changes in RMSSD are further 
elaborated in Figure 4.1 and TF, HF and LF power in Figure 4.2. 
Figure 4.1 RMSSD during Rest 1 (R1) and Stroop 1 (S1) (before the intervention) and during Rest 2
(R2) and Stroop 2 (S2) (after the intervention) in the BIO (n=9) and COM (n=9) groups
BIO = biofeedback group; COM = comparative group; RMSSD = root mean square of the successive differences; ms =
milliseconds
Time effect between Rest 1 and Stroop 1 (Wilcoxon): # P < 0.05  COM RMSSD 
Time effect between Rest 2 and Stroop 2 (Wilcoxon): # P < 0.05  COM RMSSD 











Table 4.1 Respiratory frequency, heart rate and heart rate variability measures throughout testing in the BIO (n = 9) and COM (n = 9) groups. Data are expressed as 
medians with interquartile ranges in brackets. 
BIO = biofeedback group; COM = comparative group; RF = respiratory frequency; Hz = Hertz; HR = heart rate; b/min = beats per minute; TF, HF and LF = power of the RR interval spectrum in 
total frequency, high frequency and low frequency ranges respectively; ms2 = milliseconds squared; SDNN = standard deviation of the normal to normal RR intervals; ms = milliseconds; 
RMSSD = root mean square of successive differences of RR intervals. 
Variable Group Rest 1 Stroop 1 Intervention Rest 2 Stroop 2 
RF (Hz) BIO 0.16 (0.14 – 0.20) * 0.34 (0.30 – 0.38) # 0.10 (0.10 – 0.12) ***, # 0.14 (0.12 – 0.18) **, # 0.33 (0.28 – 0.39) #
COM 0.27 (0.20 – 0.29) 0.33 (0.28 – 0.33) ## 0.27 (0.23 – 0.29) 0.25 (0.23 – 0.29) 0.32 (0.30 – 0.33) ##
HR (b/min) BIO 68 (67 – 76) 79 (71 – 81) # 73 (70 – 78) # 68 (66 – 75) ## 68 (66 – 77) ^^ 
COM 68 (60 – 70) 74 (73 – 76) # 67 (60 – 69) 66 (59 – 68)# 67 (63 – 73) #, ^^ 
TF (ms2) BIO 2636 (1851 - 4314) 957 (822 – 1534) # 5834 (2971 – 7479) * 2344 (1713 – 3626) # 1353 (1124 – 1549) #
COM 2415 (1825 – 3021) 1437 (636 – 1690) # 2381 (943 – 3552) 2428 (1443 – 3704) 2053 (606 – 2336) # 
HF (ms2) BIO 543 (172 - 708) 161 (116 – 213) # 195 (100 – 342) # 162 (114 – 301) 196 (167 – 227) 
COM 556 (306 – 744) 172 (156 – 392) 344 (241 – 491) 437 (217 – 1021) 451 (178 – 548) 
LF (ms2) BIO 1301 (889 – 1721) 399 (350 – 686) # 5159 (2719 – 7009) **, # 1132 (669 – 2679) ## 532 (482 – 667) #
COM 1013 (975 – 1867) 320 (229 – 766) # 863 (540 – 1037) 807 (623 – 1303) 740 (254 – 1361) 
SDNN (ms) BIO 55.6 (47.7 – 57.8) 48.7 (42.0 – 50.6) 74.8 (58.9 – 92.8) * 48.4 (44.6 – 65.0) # 42.9 (38.7 – 49.7) 
COM 51.5 (47.7 – 72.6) 41.0 (33.4 – 61.1) 48.8 (35.7 – 58.9) 50.5 (49.0 – 65.3) 46.0 (34.0 – 60.2) 
RMSSD (ms) BIO 30.7 (27.3 – 47.2) 21.5 (18.8 – 28.5) 40.0 (28.5 – 57.1) 28.0 (19.9 – 38.1) # 28.2 (22.4 – 28.9) ^ 











Time effect between Rest 1 and Stroop 1 (Wilcoxon) 
# P < 0.05 BIO RF, BIO HR, COM HR, BIO TF, COM TF, BIO HF, BIO LF, COM LF, COM RMSSD 
## P < 0.01 COM RF 
Time effect between Rest 1 and Intervention (Wilcoxon) 
# P < 0.05 BIO RF, BIO HR, BIO HF, BIO LF 
Time effect between Intervention and Rest 2 (Wilcoxon) 
# P < 0.05 BIO RF, COM HR, BIO TF, BIO SDNN, BIO RMSSD 
## P < 0.01 BIO HR, BIO LF 
Time effect between Rest 2 and Stroop 2 (Wilcoxon) 
# P < 0.05 BIO RF, COM HR, BIO TF, COM TF, BIO LF, COM RMSSD 
## P < 0.01 COM RF 
Time effect between Stroop 1 and Stroop 2 (Wilcoxon) 
^ P < 0.05 BIO RMSSD 
^^ P < 0.01 BIO HR, COM HR,  
Group effect (Mann-Whitney)
* P < 0.05 BIO Rest 1 RF vs. COM Rest 1 RF, BIO Intervention TF vs. COM Intervention TF, BIO Intervention SDNN vs. COM Intervention SDNN
** P <0.01 BIO Intervention LF vs. COM Intervention LF, BIO Rest 2 RF vs. COM Rest 2 RF
***P < 0.0001 BIO Intervention RF vs. COM Intervention RF 











Figure 4.2 TF power (a), HF power (b) and LF power (c) during Rest 1 (R1) and Stroop 1 (S1) (before 
the intervention) and during Rest 2 (R2) and Stroop 2 (S2) (after the intervention) in the BIO (n=9) 
and COM (n=9) groups 
BIO = biofeedback group; COM = comparative group; TF = total frequency; ms2 = milliseconds squared; LF = low frequency; 
HF = high frequency 
Time effect between Rest 1 and Stroop 1 (Wilcoxon): # P < 0.05  BIO TF, COM TF, BIO HF, BIO LF, COM LF 











4.3.2 Effects of intervention 
Respiration causes a corresponding cyclical change in heart rate that is known as respiratory sinus 
arrythmia (RSA) 659;660. The amplitude of RSA is maximal when there is resonance between the 
respiratory oscillations and the baroreflex induced Mayer wave oscillations 14. The frequency at 
which this occurs is known as resonance frequency 287 and generally occurs at about 0.1Hz or 6 
breaths/minute 226;299 which is the respiratory frequency seen in response to biofeedback in this 
study. RSA is thought to be mediated almost exclusively by parasympathetic activity 229;306, and 
increases as a result of increased cardiac vagal stimulation 229;230. 
Previous studies have shown that HRV biofeedback-induced breathing at around 0.1Hz results in an
increase in LF power, TF power 442-444 and SDNN 444, with either no change 442;444 or a decrease 443 in
HF power. In addition, a non-significant increase in HR has been documented 444.
The changes observed in the BIO group were in keeping with these findings. Compared to Rest 1, RF 
decreased (p<0.05) to 0.1 Hz during the intervention, and LF power increased (p<0.05), TF power
increased approaching significance (p=0.09) and HR incre sed (p<0.05), while HF power decreased
(p<0.05). Both SDNN and RMSSD increased but did not reach significance due to the large inter-
subject variability. Similar changes were observed in comparison to the COM group. The BIO group
had a lower respiratory frequency (p<0.001) and higher LF power (p<0.01), TF power (p<0.05) and
SDNN (p<0.05) than the COM group. No differences were found in HR, HF power or RMSSD between
groups, and the COM group showed no change from Rest 1. It is worth noting that despite the
decrease in respiratory frequency, the BIO subjects were able to maintain vagal activity in the HF 
range. These results are shown in the 3rd data column in Table 4.1.
The RSA-induced increase in LF power during biofeedback reflects increased direct cardiac 
parasympathetic activity 271;276. RMSSD also reflects the degree of cardiac vagal control and has a 
high correlation with HF power in the cardiac spectrogram 15;215. It is therefore interesting that the 
RMSSD tended to increase while the HF power decreased. 
4.3.3 Rest after intervention 
After the HRV biofeedback intervention we found a carry-over effect with a trend to greater vagal 
withdrawal in Rest 2 in comparison to Rest 1 as well as in comparison to the COM group in Rest 2. 











preceding intervention, in the BIO group respiratory frequency (p<0.05) increased, and HR (p<0.01), 
LF power (p<0.01), TF power (p<0.05) and SDNN (p<0.05) decreased. Furthermore, it is interesting 
that while HF power remained unchanged, RMSSD decreased (p<0.05). This illustrates that while 
RMSSD is more sensitive to changes in HF power, it is also impacted by large changes in LF power. 
The COM group showed no change from the intervention to Rest 2. 
Respiratory frequency, HR and all measures of HRV in both groups during Rest 2 were not different
from Rest 1, except for a strong trend for RMSSD to be lower after the intervention in the BIO group
(p=0.05). There was also a strong trend for HF power to be lower in the BIO than in the COM group
(p=0.06) after the intervention, both indicative of a shift in vagal modulation from HF to LF in the BIO 
group. The ability to effectively withdraw cardiac vagal activity is known as the vagal brake 324 and
allows healthy adaptive flexible behaviour 323. Lastly, respiratory frequency was lower in the BIO
group than in the COM group (p<0.01) while no other changes were evident between groups.
Studies have shown that the increase in baroreflex gain seen during HRV biofeedback persists into
the immediate post biofeedback period 443 resulting in increased LF power and increased SDNN 444
even when respiration rate is accounted for 443. However, in keeping with our study, others have
shown no carry over effect with respect to LF, HF or TF power 442.
4.3.4 Response to cognitive stress after the intervention
The results from Stroop 2 are shown in Table 4.1, Figure 4.1 and Figure 4.2. While there were no
differences between groups in RF, HR or any measures of HRV during Stroop 2, there was evidence
for a carry-over effect when these groups are assessed over time and intervention.
During Stroop 1, RF and HR increased, TF and LF power decreased, and RMSSD and HF power either 
decreased or showed a strong trend to decrease in both groups. After the intervention during Stroop 
2, the COM group responded similarly with an increase in RF (p<0.01) and HR (p<0.05), a decrease in 
TF power (p<0.05) and RMSSD (p<0.05) and a trend towards a decrease in HF power (p=0.07), 
however there was no change in LF power. In the BIO group, RF increased (p<0.05), TF power 












These findings indicate that while both groups experienced vagal withdrawal in response to stress, 
there was evidence for different patterns of vagal modulation in each group. It is possible that these 
different patterns occur as a result of different physiological pathways. Porges 319 has identified 2 
different branches of the vagus which have different physiological effects on the heart: a myelinated 
branch originating from the nucleus ambiguus which is important in social communication and is 
highest in the phylogenetic hierarchy, and an unmyelinated branch originating in the dorsal motor 
nucleus of the vagus which causes immobilization. Inhibition of the myelinated branch causes 
increased HR and decreased HF without change in LF (similar to the pattern seen in the COM group), 
while inhibition of the unmyelinated path may reduce LF with no change to HF power (similar to the 
pattern seen in the BIO group) 319. 
Importantly the carry over effect seen during Stroop 2 in the BIO group occurs i part as a result of a
relatively greater vagal withdrawal in Rest 2 as discussed above. In comparison to Stroop 1, HR was
lower in both groups (BIO p<0.01, COM p<0.01) and RMSSD higher in the BIO group only (p<0.05).
This suggests less HF vagal withdrawal during stress after the intervention 220 in the BIO group and, 
in effect, a reverse of the shift in vagal modulation seen in Rest 2 from LF back to HF.
Breathing at 0.1 Hz leads to increased HRV as a result of a combination of mechanisms including
gating of preganglionic vagal cardiac neural activity 289 in response to central oscillations 290, 
pulmonary and atrial stretch reflexes 237;272 and resonance with the arterial baroreflex loop 246;274;291-
293. One might speculate that activation of these mechanisms led to changes in the central structures
involved in the autonomic regulation of HRV, which persisted into the post-intervention periods. This
may have accounted for the proposed shift in activity from the unmyelinated vagus to the
myelinated vagus, resulting in increased autonomic flexibility and increased ability to adapt and
respond to environmental demands such as the Stroop task.
The neural structures involved in the autonomic regulation of HRV are linked together with 
structures involving cognitive and affective regulation 702;704;705. Through this bidirectional system, 
improved regulation of HRV could result in improved cognitive performance 702. It is, therefore, 
tempting to speculate that the different patterns of vagal withdrawal in each group may have 
contributed to the differences in cognitive performance between groups demonstrated in Chapter 3, 












A single episode of short duration biofeedback resulted in a short term carry-over effect after 
biofeedback that modified the physiological response during both the 5 min rest period and the 
following laboratory induced stress. While both groups demonstrated evidence for vagal withdrawal 
in response to induced stress, the pattern of vagal modulation in each group differed. The BIO group 
maintained HF power and RMSSD in Stroop 2 relative to the preceding rest period despite decreased 
TF and LF power, while the COM group maintained LF power despite decreased TF and HF power. 












THE EFFECT OF A SINGLE SESSION OF SHORT DURATION HRV 
BIOFEEDBACK ON EEG  
5.1 INTRODUCTION 
Extreme and chronic stress leads to increased anxiety 661. Changes in EEG are evident in anxiety, as 
well as during relaxation and meditation. Frontal theta power reflects alterations in autonomic 
nervous system activity 194;373;586;597, and increases with relaxation 580-582 and decreased anxiety 194;583-
585. In addition, relaxation causes a decrease in beta power 582. During meditation, theta power also
increases both in the frontal midline areas 194;598;602, and globally 608. While many studies have shown
an increase in alpha power 373;598;619;620, others have found this only in advanced practitioners
600;617;626.
HRV biofeedback can be viewed as a form of concentrative meditation, which involves focusing on
specific mental or sensory activities 170, in this case the breath. However, biofeedback is different in
that in addition to observing the breath, one is actively controlling it in response to an external
biofeedback stimulus. One of the key psychological factors contributing to successful meditation is
attention 173;613. Two different attentional networks have been described: an anterior network
involving the detection of sensory targets and a posterior network involving the orienting of sensory
attention 522. Changes in EEG theta, alpha and beta power, and theta/beta ratios reflect these
changes in attention and relaxation.
Observing changes in EEG during and after HRV biofeedback may contribute to understanding the 
mechanisms contributing to the improved performance shown in Chapter 3, the changes in HRV 
shown in Chapter 4 and the reduction in anxiety and increased perceived relaxation shown in 
Chapter 6. While the majority of HRV biofeedback studies use the conventional training protocol as 
described by Lehrer et al 634, the aim of this chapter is to examine the acute effect of a single 10 
minute HRV biofeedback intervention on power in the theta, alpha and beta frequency bands and 












The methodology for this chapter can be found in Chapter 2 . General methodology is described on 
pages 35 to 39, methodology regarding the measurement and analysis of EEG on page 42, and 
statistics specific to the EEG analysis on pages 44 and 45. 
5.3 RESULTS 
5.3.1 BIO intervention scores 
During the training session, scores for the BIO intervention were 41 ± 7 points, with 8 of the 9
subjects having a score above 30 and a lowest score of 29. During testing the scores were 46 ± 5
points with all scores above 30 and a lowest score of 38. A score of 30 or more is indicative of a
successful session.
5.3.2 EEG measures 
5.3.2.1 Intervention
There were no differences in absolute power between groups during the intervention (Table 5.1).
Table 5.1 Absolute power in theta, alpha and beta EEG bands at Fz, Cz and Pz during the
intervention in the BIO and COM groups (n = 8 in each group at Fz and Cz, n = 7 in each group at
Pz). Data are expressed as medians with interquartile ranges in brackets.
Variable Position BIO COM 
Theta power (µV2/Hz) Fz 0.046 (0.038 – 0.049) 0.047 (0.024 – 0.053) 
Cz 0.045 (0.037 – 0.049) 0.044 (0.026 – 0.052) 
Pz 0.038 (0.032 – 0.040) 0.046 (0.029 – 0.048) 
Alpha power (µV2/Hz) Fz 0.064 (0.053 – 0.070) 0.076 (0.047 – 0.088) 
Cz 0.065 (0.057 – 0.074) 0.085 (0.046 – 0.094) 
Pz 0.063 (0.056 – 0.074) 0.104 (0.059 – 0.119) 
Beta power (µV2/Hz) Fz 0.067 (0.056 – 0.074) 0.086 (0.063 – 0.090) 
Cz 0.074 (0.057 – 0.083) 0.082 (0.064 – 0.097) 
Pz 0.064 (0.050 – 0.081) 0.086 (0.064 – 0.091) 











Differences in relative power and the theta/beta ratio in the different frequency bands are shown in 
Figure 5.1. During the intervention relative theta power was higher in the BIO group than the COM 
group at Fz (p<0.01), Cz (p<0.05) and Pz (p<0.01). There were no differences in relative alpha power. 
Relative beta power was lower in the BIO group at Fz (p<0.05) and Cz (p<0.05), with no difference at 
Pz. In addition, the theta/beta ratio was higher in the BIO than the COM group at Fz (p<0.01), Cz 
(p<0.01) and Pz (p<0.05). 
Figure 5.1 Relative theta (a), alpha (b) and beta power (c) and theta/beta ratios (d) at Fz, Cz and Pz 
during the intervention in the BIO and COM groups (n = 8 in each in group at Fz and Cz, n = 7 in 
each group at Pz) 
BIO = biofeedback group; COM = comparative group; % = percentage. 
* P < 0.05 BIO Cz theta power vs. COM Cz theta power, BIO Fz beta power vs. COM Fz beta power, BIO Cz beta 
power vs. COM Cz beta power, BIO Pz theta/beta ratio vs. COM Pz theta/beta ratio 
** P < 0.01 BIO Fz theta power vs. COM Fz theta power, BIO Pz theta power vs. COM Pz theta power, BIO Fz 











During the intervention RF correlated negatively with % theta at Fz (r=-0.79 (-0.93 to -0.45), 
p<0.001), Cz (r=-0.76 (-0.92 to -0.40), p<0.005) and Pz (r=-0.73 (-0.92 to -0.28), p<0.01), as well as 
with theta/beta ratios at Fz (r=-0.66 (-0.88 to -0.2), p<0.01), Cz (r=-0.72 (-0.90 to -0.32), p<0.01) and 
Pz (r=-0.58 (-0.86 to -0.02), p<0.05). RF correlated positively with % beta at Fz (r=0.54 (0.02 to 0.83), 
p<0.05) and Cz (r=0.53 (0.01 to 0.83), p<0.05). Both LF and TF power correlated positively with Pz % 
theta (r=0.59 (0.03 to 0.87), p<0.05, and 0.57 (0.11 to 0.86), p<0.05, respectively). In the BIO group, 
the BIO intervention score correlated positively with the Fz % theta (r=0.77 (0.14 to 0.96), p<0.05). 
5.3.2.2 Rest 1 vs. Rest 2 
Absolute power values during Rest 1 and 2 are shown in Figure 5.2 below. While there were no
differences between groups in Rest 1, during Rest 2 Fz beta tended to be lower in the BIO than the
COM group (p=0.06). There were no differences in any of the absolute power values between Rest 1
and Rest 2 in the BIO group, while in the COM group all values increased (p<0.05).
Differences in relative power are shown in Table 5.2 below. There were no differences in either of
the 2 main effects (group and time) for any variable. There was an interaction effect (group x time)
in relative theta power at Pz (p<0.05) suggesting that the two groups responded differently over
time. The Tukey’s  post hoc test, however, failed to detect any specific differences. In addition, there
was an interaction effect (group x time) in relative beta power at Cz that approached significance
(p=0.06). No differences were found in relative theta power at Fz or Cz, in relative alpha power at











Figure 5.2 Absolute theta, alpha and beta power during Rest 1 and Rest 2 at Fz (a), Cz (b) and Pz (c)
in the BIO and COM groups (n = 8 in each group at Fz and Cz, n = 7 in each group at Pz)
BIO = biofeedback group; COM = comparative group; µV2/Hz = microvolt squared per hertz.
Time effect between Rest 1 and Rest 2 (Wilcoxon)
* P < 0.05 COM Fz theta, COM Fz alpha, COM Fz beta, COM Cz theta, COM Cz alpha, COM Cz beta, COM Pz theta,
COM Pz alpha, COM Pz beta.
Group effect (Mann-Whitney)











Table 5.2 Relative power in theta, alpha and beta EEG bands at Fz, Cz and Pz during Rest 1 and Rest 
2 in the BIO and COM groups (n = 8 in each group at Fz and Cz, n = 7 in each group at Pz) 
Variable Group Rest 1 Rest 2 
Relative Theta power (%) 
Fz BIO 22.7 ± 2.3 22.9 ± 2.4  
COM 19.6 ± 3.5 19.5 ± 4.2 
Cz BIO 20.9 ± 2.4 21.4 ± 2.5 
COM 18.7 ± 3.5 18.7 ± 4.2 
Pz BIO 18.0 ± 2.4 19.2 ± 2.9  
COM 16.5 ± 3.3 16.1 ± 4.2
Relative Alpha power (%) 
Fz BIO 40.4 ± 5.3 40.6 ± 6.5 
COM 43.4 ± 7.0 42.8 ± 7.2 
Cz BIO 41.9 ± 5.8 42.1 ± 7.3 
COM 43.4 ± 7.4 42.0 ± 7.1 
Pz BIO 46.5 ± 7.1 45.3 ± 8.4 
COM 47.9 ± 8.6 47.9 ± 9.6 
Relative Beta power (%) 
Fz BIO 37.0 ± 5.1 36.5 ± 6.2 
COM 37.1 ± 5.5 37.8 ± 5.6 
Cz BIO 37.2 ± 4.9 36.5 ± 6.2 
COM 37.9 ± 6.0 39.3 ± 6.2 
Pz BIO 35.5 ± 5.4 35.5 ± 6.2 
COM 35.7 ± 6.6 36.0 ± 6.6 
% = percentage; BIO = biofeedback group; COM = comparative group. 
* P < 0.05 Interaction effect: Pz relative theta (group x time) 













Differences in theta/beta ratios are shown in Figure 5.3. While there was no significant difference in 
theta/beta ratio at Fz, interaction effects (group x time) were found at both Cz (p<0.01) and Pz 
(p<0.01).  Tukey’s  post hoc test revealed a significant increase in theta/beta ratio at Pz from Rest 1 to 
Rest 2 in the BIO group (P<0.05), while at Cz it failed to detect any specific differences. 
Figure 5.3 Theta/beta ratios at Fz (a), Cz (b) and Pz (c) during Rest 1 and Rest 2 in the BIO and COM 
groups (n = 8 in each group at Fz and Cz, n = 7 in each group at Pz) 
BIO = biofeedback group; COM = comparative group. 
* P < 0.05 Rest 1 BIO Pz theta/beta ratio vs. Rest 2 BIO Pz theta/beta ratio 












The main finding of this study is that a single short duration episode of HRV biofeedback resulted in 
EEG changes suggestive of increased attention as well as increased relaxation and reduced anxiety 
both during and after the intervention, while the comparative intervention resulted in changes 
suggestive of increased mental effort and anxiety. 
5.4.1 EEG changes during the intervention 
During the intervention, relative theta power was higher in the BIO group than the COM group at all
3 electrodes suggesting increased internal attention 476;477;516;608 both in the anterior and posterior
networks 522. Activity in the anterior network commonly increases during meditation 662;663, while 
activation of the posterior attention network increases as subjects actively regulate their breath in
response to biofeedback increasing posterior visuo-motor integration 485.
In addition, the BIO group experienced EEG changes suggestive of increased relaxation, decreased
anxiety and decreased mental effort. The higher frontal relative theta power seen in the BIO group is 
associated with activation of the parasympathetic nervous system 373;586;597, while both the higher 
theta and lower fronto-central relative beta p wer suggest increased relaxation 580-582;582. Higher
frontal theta is also associated with decreased anxiety 194;583;585, and the higher theta/beta ratios
seen in the BIO group at all 3 electrodes suggest decreased mental effort 465.
These findings are in keeping with other studies which show that some forms of meditation result in
concurrent increased internal attention and relaxation 662;664 causing a state in which the brain is 
‘calm and relaxed,  yet awake  and alert’   662. While no other studies have evaluated changes in EEG
during HRV biofeedback, similar changes are seen during meditation. Theta power increases both in
the frontal midline area 194;598;602 and globally 608;662, and theta/beta ratios increase globally
suggesting increased attention and visual imagery 665.
Subjects achieved sufficient StressEraser scores both during training and during the intervention to 
indicate adequate mastery of the biofeedback requirements. This suggests that despite the short 
duration of the intervention and the single training session, subjects used the device effectively. 











0.01 Hz, suggesting that they achieved a similar frequency as targeted in traditional HRV biofeedback 
using frequency analysis. 
All of the EEG changes observed during HRV biofeedback are correlated with decreased respiratory 
frequency. The HRV biofeedback device guides subjects to find their optimal slow respiration rate 635 
and as a result the BIO group had a lower respiratory frequency than the COM group. Furthermore, 
there was a dose effect with the subjects who had higher HRV biofeedback intervention scores 
having increased frontal relative theta power. This suggests that those who used the intervention 
more effectively experienced greater internal attention and relaxation. 
EEG was also correlated with HRV. The only other study to examine the relationship between HRV
and EEG showed a positive correlation between HF HRV power and frontal midline theta power 
during meditation which was most likely mediated by increased activation of the parasympathetic
nervous system 587. While we did not find a correlation between EEG and HF power, we did find that 
both LF and TF HRV power were positively correlated with posterior relative theta power. We do not
know the explanation for the association between these variables, however, both are related to
breathing. LF and TF power increase when one breathes at 0.1 Hz during HRV biofeedback 443, and
posterior theta power increases with increased posterior visuo-motor integration 485 as subjects
regulate their breath during biofeedback.
The comparative intervention resulted in higher fronto-central relative beta power as well as lower
theta/beta ratios at all 3 electrodes, both suggestive of increased mental effort 666;465. This
intervention required a constant cognitive state potentially contributing to the increase in beta
activity 467. Increased mental effort may have been required to maintain this constant cognitive
state.
No differences were found in alpha power between groups during the intervention. This is in 
keeping with other studies which have found no difference when comparing meditation with 
relaxation 204;608;633, as both biofeedback and the comparative intervention could be considered 
forms of meditation and both resulted in relaxation as indicated by the questionnaire results. 











5.4.2 EEG changes in the immediate post intervention period 
In the BIO group, increased posterior relative theta power, decreased central relative beta power 
and increased central and posterior theta/beta ratios suggest that HRV biofeedback resulted in 
increased internal attention in the posterior network 522;608 together with increased relaxation 582 
which persisted after the intervention. This is in keeping with questionnaire results, reported in 
Chapter 6, which indicated that the BIO subjects felt alert and relaxed. The BIO group were most 
likely still focused on and aware of the sensation of their breath, resulting in increased sensory 
attention and, therefore, increased posterior relative theta power 522. 
EEG changes in the COM group suggest increased mental effort and anxiety. Increased central beta
power suggests that the subjects experienced greater mental effort 666. After the comparative
intervention, subjects felt sleepy and relaxed (results shown in Chapter 6) and as a result possibly
needed to exert increased mental effort to maintain a constant cognitive state. In addition, they may
have felt some anxiety 594 as they knew that they were not supposed to fall asleep. Furthermore,
absolute power in all frequency bands at all 3 electrodes increased in the COM group relative to the
first rest period. A global increase in EEG power has previously been described in response to
anxiogenic situations 595, but could conceivably be caused by electrical interference created by low 
grade EMG activation likely resulting from anxiety.
The only other study to examine the effects of HRV biofeedback on changes in EEG used a similar
protocol but with a 15 minute intervention 596. The authors found that biofeedback resulted in
increased theta and alpha power after the intervention, while no differences in beta power were
found 596. It is possible that the extra 5 minutes of intervention provided enough additional stimulus
to increase the alpha power at rest. It is, however, difficult to make a direct comparison as the
authors state an overall power value obtained from 19 electrodes in a 10-20 montage   and don’t
state specific findings at Fz, Cz or Pz. In addition, subjects in their study had open eyes and in ours
closed eyes, possibly affecting the alpha power 537;538.
A single episode of 10 minutes of HRV biofeedback has proven to be beneficial; however the EEG 
changes found in this study differ slightly to those found in response to a similar intervention of 
longer duration 596. It would therefore be beneficial to measure the effect of varying durations of a 











as long term use is unknown. In particular, as users achieve mastery of the HRV biofeedback one 
might expect to see changes in alpha power 600;617;626. 
One of the limitations of the interpretation of EEG and, specifically, EEG frequency analysis is that 
the underlying mechanisms are not yet completely understood. A single oscillation can reflect many 
different processes and be generated in many different areas 478;471. As a result, changes that occur 
during complex tasks may be non-specific 488;489 and, therefore, difficult to interpret. Furthermore, 
some of these processes and underlying neural networks have been identified, while many have not. 
One might, therefore, interpret EEG according to the current understanding, however, there may be 
additional relevant associations that have not yet been described. 
5.5 CONCLUSION 
In conclusion, a single episode of short duration HRV biofeedback induced relative EEG changes
during the intervention compared to the comparative intervention. While the absolute power was
similar in the two groups, HRV biofeedback resulted in higher relative theta power and theta/beta
ratios at Fz, Cz and Pz, and lower fronto-central relative beta power in comparison to the control. In
the post intervention rest period, the COM group had increases in absolute power over all
frequencies at Fz, Cz and Pz, while the BIO group showed no change in absolute power relative to
the first rest period. In addition, the groups showed different responses to the intervention with
changes in posterior theta, central beta and central-posterior theta/beta, and the posterior 
theta/beta ratio increased in the BIO group from Rest 1 to Rest 2.
These findings suggest that HRV biofeedback resulted in increased attention together with increased 
relaxation during the intervention persisting into the post intervention period. Furthermore, those 
who used the intervention more effectively experienced greater internal attention and relaxation. In 
contrast, the comparative intervention caused increased mental effort possibly in response to the 
need to maintain a constant cognitive state both during and after the intervention, as well as 
possible anxiety in the post intervention period. 












THE EFFECT OF A SINGLE SESSION OF SHORT DURATION HRV 
BIOFEEDBACK ON MEASURES OF ANXIETY AND RELAXATION 
STATES  
6.1 INTRODUCTION 
As a result of the high prevalence of stress and the growing burden of stress-related anxiety 20;661 and
disease 8-12, it is increasingly important to identify effective stress management techniques.
Interventions that are commonly used to reduce stress and anxiety include techniques such as
progressive muscle relaxation 161;162, listening to relaxing and classical music 168;169, cognitive
behavioural interventions 159 and meditation 176;177;179. Heart rate variability biofeedback is another
intervention which has recently shown promise 195;196.
Most relaxation techniques result in a non-specific relaxation characterised by decreased
sympathetic arousal 200 and lead to a reduction of stress and anxiety 177;201;202. However, different
techniques may produce different specific effects 203;204. Davidson has differentiated between
cognitive and somatic relaxation effects 205, while Smith has identified 4 different relaxation states
including mindfulness, energized positive feelings, basic relaxation and transcendence 206.
Mindfulness is a quality of attention rather than a technique 668 and is characterised by a
combination of complete awareness of internal and external stimuli together with non-judgement
669-671. It has been shown to increase as a result of meditation 668;672;673 as well as in response to HRV
biofeedback in combination with mindfulness training 674. It induces a state of relaxed alertness 200
and is associated with decreased anxiety 668, increased well being 672, EEG changes suggestive of
increased positive emotions 662 as well as increased cognitive performance 675-677.
The category of energized positive feelings includes the subcategories of feeling energized, as well as 
positive emotions or states of mind including happiness, hope, optimism, love and thankfulness. 
While no studies have examined the effect of HRV biofeedback on any of these emotions or states, 
other relaxation techniques have been associated with increased feelings of happiness 678 and joy 679. 











the ability to manage stress 682 and stress related health problems 681. Furthermore, they contribute 
to improved cognitive performance 683;684. 
The category of basic relaxation reflects the non-specific relaxation seen in response to most 
relaxation techniques 200 and consists of both physical and mental relaxation. While no studies have 
evaluated the effects of HRV biofeedback on feelings of relaxation, it has been shown to increase 
cardiac parasympathetic activity 444. The final category of transcendence includes the feelings of awe 
and wonder, prayerfulness, deep mystery and timelessness. Transcendence is defined as the ability 
to  move  beyond  ‘self-centred  consciousness’  taking  on  a  broader, clearer perspective 685-687 and has 
been positively associated with emotional wellbeing 688. The practice of Zen meditation has been 
associated with increased prayerfulness 689, however no studies have investigated the effect of HRV 
biofeedback on forms of transcendence. 
The aim of this chapter is to conduct a detailed analysis of these attributes and determine the 













The methodology for this chapter can be found in Chapter 2 . General methodology is described on 
pages 35 to 39, methodology regarding the questionnaires on pages 40 and 41, and statistics specific 
to the analysis of the questionnaire data on pages 44 and 45. 
6.3 RESULTS 
6.3.1 STAIT and STAIS 
There was no difference between groups in the STAIT questionnaire (48 ± 6 vs. 44 ± 7 units, BIO vs.
COM), and no correlation between trait anxiety (STAIT) and pre-testing state anxiety (STAIS) was
found. Results from the STAIS are shown in Figure 6.1 below. Analysis revealed a time effect
(p<0.001), with no group or interaction (group x time) effects. Effect sizes were -1.17 for the BIO
group and -0.72 for the COM group. Normative data for the STAIT/S indicate that values between 20
to 30 are regarded as normal and anxiety free, while values of more than 30 are associated with
various degrees of anxiety 636. Scores for the STAIT and pre-testing STAIS for both BIO and COM
groups were associated with anxiety, while the scores for the post-testing STAIS were on the margin
of normal. Changes in STAIS from pre- to post-testing correlated negatively with change in the SRSI3
total relaxation scores (r=-0.58 (CI 95% -0.83 to -0.13), p<0.05) as well as with change in the SRSI3
basic relaxation scores (r=-0.66 (CI 95% -0.86 to -0.26), p<0.01).
6.3.2 SRSI3 
SRSI3 total relaxation state scores and scores for the main categories are shown in Figure 6.1 below. 
Comparison of the total relaxation state scores before and after testing revealed both an interaction 
(group   x   time)   (p<0.05)   and   a   time   (p<0.001)   effect,   with   no   group   effect.   Tukey’s   post hoc test 
showed an increase in total score in the BIO group (p<0.001) from pre to post testing. Effect sizes 
were 1.14 for the BIO group and 0.40 for the COM group. 
The SRSI3 total score is divided into 4 main categories: mindfulness, energized positive feelings, 
basic relaxation and transcendence. Analysis of these categories revealed interaction (group x time) 
effects for mindfulness (p<0.05) and energized positive feelings (p<0.05) from pre- to post-testing. 













(p<0.01) and energized positive feelings (p<0.05). In addition, there was a time effect for 
mindfulness (p<0.01), basic relaxation (p<0.001), and transcendence (p<0.05). Effect sizes were also 
calculated for each category. In the category of mindfulness the effect size was 1.21 for the BIO 
group and 0.67 for the COM group, energized positive feelings showed an effect size of 0.86 for the 
BIO group and -0.12 for the COM group, basic relaxation 1.21 for the BIO group and 0.67 for the 
COM group, and for transcendence 0.56 for both the BIO and COM groups. 
Subcategory scores are shown in Table 6.1 below. In the first category of mindfulness, there were 
interaction  effects  for  mindful  quiet  (p<0.05)  and  innocence  (p<0.05).  Tukey’s  post hoc test revealed 
that the BIO group increased their scores for both mindful quiet (p<0.001) and mindful innocence 
(p<0.01). In addition, there were time effects for mindful quiet (p<0.0001), mindful innocence 
(p<0.01), mindful acceptance (p<0.05) and mindful centering (p<0.01), and a group effect for mindful 
awareness (p<0.05). No group, time or interaction (group x time) effects were found for mindful 
awakening. 
In the category of energized positive feelings, there was a time effect (p<0.05) for the category of 
energized. No group, time or interaction (group x time) differences were found for 
optimism/hope/trust, happiness or feeling thankful and loving. 
In the category of basic relaxation, there was an interaction effect for feeling rested and refreshed 
(p<0.05).  Tukey’s  post hoc test revealed that the BIO group felt more rested and refreshed after than 
before testing (p<0.01). In addition, there were time effects for rested and refreshed (p<0.01), 
disengagement (p<0.01), physical relaxation (p<0.001) and mental relaxation (p<0.01). No group, 
time or interaction (group x time) effects were found for sleepiness before and after testing. 
Finally in the category of transcendence, no group, time or interaction (group x time) differences 
were found for awe and wonder, feeling prayerful, deep mystery or feeling 
timeless/boundless/infinite. 
6.3.3 Scores for helpfulness and sleepiness 
There were no differences in scores for helpfulness of the device (7 ± 1 vs. 6 ± 2 units, BIO vs. COM) 











minutes of using the device, however the COM group felt more sleepy than the BIO group (5 ± 3 vs. 
7 ± 2 units, BIO vs. COM, p<0.05) during the rest period after the intervention (Rest 2). 
Figure 6.1 Scores for STAIS (a), SRSI3 Total Relaxation States (b), SRSI3 Mindfulness (c), SRSI3 
Energized Positive Feelings (d), SRSI3 Basic Relaxation (e) and SRSI3 Transcendence (f) before and 
after testing in the BIO (n=9) and COM (n=9) groups 
BIO = biofeedback group; COM = comparative group; STAIS = Spielberger State Anxiety Inventory; SRSI3 = Smith Relaxation 
States Inventory 3. 
* P<0.05 Positive feelings BIO pre vs. BIO post  
** P<0.01 Mindfulness BIO pre vs. BIO post 
*** P<0.001 Total score BIO pre vs. BIO post 
# P<0.05 Interaction (group x time) effect: Total score, Mindfulness, Positive feelings 
^ P<0.05 Time effect: Transcendence  
^^ P<0.01 Time effect: Mindfulness 













Table 6.1 Scores for each individual subcategory in the Smith Relaxation States Inventory 3 before 
and after testing in the BIO (n=9) and COM (n=9) groups 
Variable Group Before After Group Time Interaction  
MINDFULNESS       
Mindful quiet BIO 2.22 ± 1.25 ** 4.28 ± 0.87 **    NS P<0.0001 P<0.05 
 COM 2.67 ± 1.27 3.56 ± 1.10                    
Mindful innocence BIO 1.44 ± 0.53 * 2.44 ± 1.01 *           NS P<0.01 P<0.05 
 COM 1.44 ± 0.53 1.56 ± 0.73                    
Mindful acceptance BIO 3.39 ± 1.11 4.11 ± 1.11                NS P<0.05 NS 
 COM 3.35 ± 1.41 3.56 ± 1.01    
Mindful centering BIO 2.89 ± 0.93  3.94 ± 0.95             NS P<0.01 NS 
 COM 3.06 ± 0.92 3.61 ± 1.19    
Mindful awareness BIO 4.00 ± 1.22 4.67 ± 0.71                      P<0.05 NS NS 
 COM 3.44 ± 1.13 3.11 ± 1.36     
Mindful awakening BIO 2.22 ± 1.39 2.78 ± 1.56 NS NS NS 
 COM 2.67 ± 1.41 2.33 ± 0.87    
ENERGIZED POSITIVE FEELINGS       
Energized BIO 2.56 ± 1.24  3.89 ± 0.93               NS P<0.05 NS 
 COM 3.00 ± 1.41 3.11 ± 1.27    
Optimism/hope/trust BIO 4.00 ± 1.22 4.22 ± 1.20 NS NS NS 
 COM 3.33 ± 1.32 3.33 ± 0.87    
Happy  BIO 3.28 ± 0.67 3.67 ± 0.56 NS NS NS 
 COM 3.61 ± 0.89 3.39 ± 0.93    
Thankful and loving BIO 3.17 ± 0.87 3.44 ± 0.73 NS NS NS 
 COM 3.11 ± 1.02 2.83 ± 0.75    
BASIC RELAXATION       
Rested/refreshed BIO 2.22 ± 1.39 * 4.00 ± 0.87 *            NS P<0.01 P<0.05 
 COM 2.22 ± 1.30 2.44 ± 1.42                   
Disengagement BIO 2.17 ± 1.09  3.22 ± 1.35              NS P<0.01 NS 
 COM 2.28 ± 0.83 2.67 ± 1.20    
Physical relaxation BIO 1.77 ± 0.52  3.10 ± 0.95             NS P<0.001 NS 
 COM 1.88 ± 1.03  2.84 ± 1.06    
Mental relaxation BIO 2.85 ± 0.98 3.55 ± 1.09                 NS P<0.01 NS 
 COM 2.66 ± 1.16 3.26 ± 0.73    
Sleepiness BIO 1.67 ± 1.27 2.22 ± 0.79 NS NS NS 
 COM 2.00 ± 1.35 2.50 ± 1.00    
TRANSCENDENCE       
Awe and wonder BIO 2.61 ± 0.93 3.00 ± 1.32 NS NS NS 
 COM 1.78 ± 0.67 2.44 ± 1.01    
Prayerful BIO 2.33 ± 1.22 3.00 ± 1.21 NS NS NS  
 COM 2.11 ± 1.27 2.22 ± 1.09    
Deep mystery BIO 2.56 ± 1.24 2.78 ± 1.20 NS NS NS 
 COM 2.33 ± 1.00 2.56 ± 1.24    
Timeless, boundless, infinite BIO 2.44 ± 0.88 3.00 ± 1.41  NS NS NS 
 COM 2.00 ± 1.22 2.56 ± 1.13    
Interaction = (group x time); BIO = Biofeedback group; COM = Comparative group; NS = non significant. 
* P < 0.01  BIO rested/refreshed before vs. BIO rested/refreshed after 
BIO mindful innocence before vs. BIO mindful innocence after  












The main finding of this study is that a single session of short duration HRV biofeedback resulted in 
large improvements in total relaxation state scores as well as in scores for mindfulness, energized 
positive feelings and basic relaxation from pre- to post-testing. These changes occurred despite the 
stress induced by the Stroop task 438. In contrast, the comparative intervention resulted in only a 
small increase in overall total relaxation states scores, with a moderate improvement in basic 
relaxation, a small improvement in mindfulness and no improvement in energized positive feelings. 
While both interventions resulted in improvement in overall mindfulness as well as several of the
subcategories of mindfulness, HRV biofeedback resulted in greater improvements than the
comparative intervention, both in overall mindfulness as well as in the subcategories of mindful
quiet and mindful innocence. This suggests that subjects using the HRV biofeedback increased their
awareness of internal and external stimuli 669-671. Increased mindfulness has been associated with
decreased anxiety 668 and increased well being 672, as well as with a state of relaxed alertness 200. 
Furthermore, it is associated with improved ability to sustain attention 677 and increased cognitive
performance 675-677. While mindfulness has been shown to increase as a result of meditation 677 as
well as in response to HRV biofeedback in combination with mindfulness training 674, this is the first
study to look at the effect of HRV biofeedback alone.
HRV biofeedback also resulted in a large increase in the overall category of energized positive
feelings, while the comparative intervention showed no improvement. Both groups did, however,
have increases in the subcategory of feeling energized. The increased positive emotions seen in the
BIO group may be associated with the concurrent increases in mindfulness 662. Positive emotions
lead to increased emotional well-being 680 and reduced anxiety 681,   and improve   one’s   ability to
manage stress and adversity 682 as well as stress-related health problems 681. Furthermore, positive 
emotions broaden attention 683 and are associated with improved cognitive performance 683;684. It is
tempting to speculate that the increased positive energy together with the increased mindfulness in
the BIO group contributed to the increased cognitive performance during the Stroop task following
the intervention (reported in Chapter 3). While other relaxation techniques have been associated
with increased feelings of happiness 678 and joy 679, no other studies have looked at the effect of HRV













Both interventions led to increased scores in the category of basic relaxation. This is perhaps not 
surprising, as both interventions involve focusing attention on a single variable, which has been 
shown to increase relaxation 690. However, the HRV biofeedback had a large effect size and the 
comparative intervention a moderate effect size, suggesting that greater benefit is achieved when 
focused attention was combined with biofeedback-induced slow breathing. While no studies have 
examined the effects of HRV biofeedback on feelings of relaxation, it has been shown to increase 
cardiac parasympathetic activity 444. 
In the subcategories of basic relaxation, both groups improved physical and mental relaxation, and 
felt more disengaged and more rest and refreshed after testing, however the BIO group had a 
greater improvement in the latter. While there were no differences in sleepiness before or after 
testing between groups, the VAS score revealed that the COM group felt sleepier than the BIO group 
during the rest period immediately after the intervention. This may be suggestive of somatic 
relaxation in the BIO group, and both cognitive and somatic relaxation in the COM group 205. 
Furthermore, this may reflect relaxed alertness associated with the increased mindfulness  200 seen 
in the BIO group. 
In the last category of transcendence, there was a time effect with both groups increasing their 
overall scores moderately; however there were no changes in the subcategories. This suggests that 
both groups achieved a clearer awareness 686 and broader perspective  687, which has been 
associated with emotional wellbeing 688. While increased prayerfulness has been associated with the 
practice of Zen meditation 689, no studies have looked at the effect of HRV biofeedback on forms of 
transcendence. 
In addition to changes in relaxation states, changes in measures of anxiety were found. Both groups 
felt less anxious after testing as indicated by a significant time effect. While there was no interaction 
effect, the BIO group had a large effect size and the COM group a moderate effect size. A similar 
study revealed that both the HRV biofeedback and comparative intervention groups experienced 
decreased state anxiety, with the HRV biofeedback group having a greater decrease 195. The authors 
used a 15 minute intervention as opposed to the 10 minute intervention in this study, which could 
have accounted for the additional interaction effect. Other studies have also shown a reduction in 











The decrease in state anxiety in both groups over testing correlated with increased total relaxation 
and basic relaxation scores, as one would expect 177;201;691. There was no correlation between state 
and trait anxiety. State anxiety is the acute anxiety experienced in response to a specific stressful 
event 692, while trait anxiety is ongoing anxiety which is regarded as a relatively stable personality 
trait 692;693. While the level of state anxiety is affected by trait anxiety 694, the correlation is not direct 
as state anxiety is also affected by the specific stressors to which one is exposed 694. 
The   hand held HRV   biofeedback   device   is   easy to use,   doesn’t   require   the   assistance   of   other
individuals and can be used for short periods of time as needed throughout the day. Furthermore,
benefit is derived from a single session of biofeedback and a single training session. These findings 
together with other research suggest that HRV biofeedback would be a valuable intervention to
include in the management of stress and anxiety 195;196 as well as in the treatment and prevention of
stress and anxiety related disorders 197;444.
6.5 CONCLUSION 
In conclusion, while both interventions facilitated reduced anxiety and increased scores for total
relaxation states, mindfulness, basic relaxation and transcendence, HRV biofeedback had added
benefit with greater increases in scores for total relaxation states, mindfulness and basic relaxation,
as well as increased energized positive feelings. Further, while there was no difference in sleepiness
after testing, immediately after the intervention the HRV biofeedback group felt alert, while the












SUMMARY, CLINICAL APPLICATION AND CONCLUSIONS 
7.1 OVERVIEW AND CLINICAL INTERPRETATION 
The objective of this thesis was to examine the effects of a single 10 minute episode of HRV 
biofeedback on measures of HRV and EEG during and immediately after the intervention, measures 
of HRV and cognitive performance during laboratory induced cognitive stress and subjective feelings 
of anxiety and relaxation states after testing. 
The majority of research on HRV biofeedback focuses primarily on clinical outcomes and, therefore,
the long term effect of biofeedback over sessions. Furthermore, most use the conventional training
protocol as described by Lehrer. This thesis examines the acute effect of a single short duration HRV
biofeedback intervention. While other studies have investigated the changes in HRV both during and
immediately after HRV biofeedback, the effect of HRV biofeedback on changes in HRV during stress 
has not been previously examined. Further, no other studies have examined the effect of HRV
biofeedback on EEG during biofeedback, only one other study has investigated the changes in EEG
after biofeedback and only one other the effect of HRV biofeedback on cognitive performance.
Finally, while other studies have examined levels of stress and anxiety in response to HRV
biofeedback, none have examined changes in perceived relaxation states.
7.1.1 Chapter 3 
Chapter 3 examined the effect of HRV biofeedback on cognitive performance during laboratory-
induced stress. In summary, the data showed that: 
1. Both groups improved their reaction times in response to cues from Stroop 1 (before the
intervention) to Stroop 2 (after the intervention)
2. HRV biofeedback resulted in a greater improvement in reaction time as well as greater
consistency of responses from Stroop 1 to Stroop 2 than the comparative intervention
3. All 8 of the subjects using HRV biofeedback increased their reaction times by more than 5%,
while only 3 of the 8 subjects using the comparative intervention improved more than 5%











In conclusion, these data suggest that while both interventions resulted in an improvement in 
performance, HRV biofeedback resulted in greater improvements with both greater increases in 
reaction time and greater reduction in mistakes made. This suggests that HRV biofeedback resulted 
in improved working memory as well as possible improvements in mental set shifting, suppression of 
prepotent responses, and increased attention and focus. 
7.1.2 Chapter 4 
To further understand the physiological changes underlying the effect of HRV biofeedback, measures
of HRV and EEG were analysed. Chapter 4 examined the effect of HRV biofeedback on measures of
HRV during and immediately after the intervention, as well as during the following laboratory
induced stress. In summary, the data showed that:
During the intervention 
1. In comparison to Rest 1, respiratory frequency decreased to 0.1 Hz, LF power increased, TF
power increased approaching significance and HF power decreased during HRV biofeedback,
while no changes were evident during the comparative intervention.
2. The BIO group had a lower respiratory frequency and higher LF power, TF power and SDNN than
the COM group.
In the immediate post intervention rest period
1. In comparison to the preceding intervention, in the BIO group respiratory frequency increased,
and HR, LF power, TF power, SDNN and RMSSD decreased, while HF power remained
unchanged. The COM group showed no change from the intervention to Rest 2.
2. There was a trend for RMSSD to be lower after the intervention in the BIO group, as well as a
trend for HF power to be lower in the BIO than in the COM group, both indicative of a shift in
vagal modulation from HF to LF in the BIO group.
During Stroop 2 
1. During Stroop 2, both groups had increased respiratory rates indicative of increased sympathetic
activity, and decreased TF HRV power indicative of cardiac vagal withdrawal in comparison to
the preceding rest period. However, the pattern of vagal withdrawal was different in each group:












- The comparative intervention resulted in increased heart rate, maintained LF power and
decreased RMSSD and a trend towards a decrease in HF power.
2. In comparison to Stroop 1, HR was lower in both groups and RMSSD higher in the BIO group
only.
In conclusion, HRV biofeedback resulted in a short term carry-over effect after biofeedback that 
modified the physiological response during both the 5 min rest period and the following laboratory-
induced stress. 
Porges identifies 3 different autonomic influences on the heart. The myelinated vagal system affects
HF power and increases the ability to engage and communicate socially. The sympathetic nervous 
system results in mobilization in response to stress. Finally, the phylogenetically lowest system, the
unmyelinated vagus causes immobilization and is reflected by LF HRV spectral power.
In the immediate post-biofeedback rest period there was a trend to greater HF vagal withdrawal
after HRV biofeedback. Previous studies have shown that the ability to withdraw myelinated cardiac
vagal activity is indicative of healthy adaptive physiology associated with adaptive cognitive function, 
allowing the individual to rapidly engage with the environment as needed and increase the ability to
sustain attention.
While both groups demonstrated evidence for vagal withdrawal in response to induced stress, the
pattern of vagal modulation in each group differed, with the BIO group maintaining HF power and
RMSSD in Stroop 2 relative to the preceding rest period despite decreased TF and LF power, and the
COM group maintaining LF power despite decreased TF and HF power.
Changes in response to the comparative intervention suggest withdrawal of the beneficial social 
engagement system and increased sympathetic activation affecting the heart and increasing 
respiratory rate, with no change in unmyelinated vagal activity. However, HRV biofeedback resulted 
in changes suggestive of maintained myelinated vagal cardiac activation, no increase in sympathetic 
stimulation of the heart and withdrawal of unmyelinated vagal cardiac stimulation in the face of 
stress. While there was no sympathetic effect on the heart, there was on respiratory rate. According 
to   Porges’   polyvagal theory, this pattern of vagal withdrawal would allow effective social 











7.1.3 Chapter 5 
This chapter examined the effect of HRV biofeedback on measures of EEG during and immediately 
after the intervention. In summary, the data show that: 
During the intervention 
1. HRV biofeedback resulted in higher frontal, central and parietal theta/beta ratios and relative
theta power, and lower frontal and central relative beta power than the comparative
intervention.
2. Respiratory frequency correlated negatively with frontal central and parietal theta/beta ratios
and relative theta power, and positively with frontal and central relative beta power. Posterior
relative theta also correlated with LF and TF cardiac spectral power.
3. The BIO intervention score correlated positively with frontal relative theta power.
During rest immediately after the intervention 
1. The HRV biofeedback and the comparative device resulted in significantly different effects on
centro-parietal theta/beta ratios, parietal relative theta power and central relative beta power.
- After HRV biofeedback, theta/beta increased posteriorly and appears to increase centrally, 
relative theta power appears to increase posteriorly and beta power tends to decrease
centrally.
- After the comparative intervention, theta/beta appears to decrease centrally and
posteriorly, and relative beta power tends to increase centrally.
2. There was no change in absolute power after HRV biofeedback, while the comparative 
intervention led to increases in absolute theta, alpha and beta power at all locations. Absolute
frontal beta power tended to be lower in the BIO group than the COM group.
In conclusion, these findings suggest that a single episode of short duration HRV biofeedback 
resulted in EEG changes suggestive of increased attention together with increased relaxation during 
the intervention and persisting into the post intervention period. In contrast, the comparative 
intervention resulted in changes suggestive of increased mental effort, possibly in response to the 
need to maintain a constant cognitive state, both during and after the intervention, as well as 
possible anxiety in the post-intervention period. It is tempting to speculate that the increased 
attention during rest in the HRV biofeedback group contributed to the improved cognitive 











All of the EEG changes observed during HRV biofeedback are correlated with decreased respiratory 
frequency which occurs during biofeedback. Furthermore, there was a dose effect suggesting that 
subjects who used the HRV biofeedback intervention more effectively experienced greater internal 
attention and relaxation. 
7.1.4 Chapter 6 
Finally, this chapter examined the acute effect of HRV biofeedback on feelings of sleepiness after 
using the intervention, as well as perceived anxiety and relaxation states after testing. The main 
findings were: 
1. The COM group felt more sleepy than the BIO group during the rest period immediately after the
intervention
2. Both groups felt less anxious after testing, with the HRV biofeedback resulting in a large effect
size and the comparative intervention a moderate effect size.
3. Both groups felt more relaxed after testing with increases in total relaxation scores, increases in
the categories of mindfulness, basic relaxation and transcendence, and increases in the
subcategories of mindful quiet, mindful innocence, mindful acceptance, mindful centering,
feeling energized, feeling rested and refreshed, disengagement, physical relaxation and mental
relaxation.
4. HRV biofeedback resulted in greater increases in total relaxation scores, greater increases in the
categories of mindfulness and basic relaxation, and greater increases in the subcategories of
mindful quiet, mindful innocence and feeling rested and refreshed. In addition, HRV biofeedback
led to increases in the category of energized positive feelings.
In conclusion, while both interventions facilitated reduced anxiety and increased perceived 
relaxation, HRV biofeedback had added benefit with greater increases in scores for total relaxation 
states, mindfulness and basic relaxation, as well as increased energized positive feelings. Increased 
mindfulness has been associated with decreased anxiety as well as with a state of relaxed alertness, 
and both mindfulness and positive emotions are associated with improved attention and cognitive 
performance. It is tempting to speculate that the increased mindfulness together with increased 
positive energy in the BIO group may have contributed to the increased cognitive performance 
during Stroop 2. Increased perceived relaxation would also be in keeping with the changes evident in 











Further, while there was no difference in sleepiness after testing, immediately after the intervention 
the HRV biofeedback group felt alert, while the comparative group felt sleepy. The perception of 
alert relaxation immediately after HRV biofeedback supports the EEG findings of concurrent 
increased attention and relaxation. 
Figure 7.1 Summary of the effects of a single episode of HRV biofeedback on HRV, EEG, cognitive 
performance and perceived anxiety and relaxation states 
In conclusion, while there is benefit to maintaining focused attention on a single variable as shown 
by the improvements in the comparative group, there is greater benefit in combining focused 
attention with HRV biofeedback. A single 10 minute HRV biofeedback intervention led to improved 
cognitive performance, HRV changes suggestive of improved vagal modulation, EEG changes 













perceived anxiety and relaxation states. HRV biofeedback, therefore, provides an effective, 
inexpensive and time efficient tool that could be a useful aid for improving cognitive performance in 
the face of stress, as well as a valuable component in the management of stress and disease, both 












7.2 CLINICAL APPLICATION 
The findings of this thesis offer new insight into an effective and readily accessible stress 
management technique. A single 10 minute HRV biofeedback intervention led to a reduction in 
perceived anxiety and an increase in perceived relaxation states. Furthermore, it led to HRV changes 
suggestive of an improved autonomic response to stress, with evidence for an increase in HRV 
during induced stress as indicated by the increase in RMSSD from Stroop 1 to Stroop 2. 
This has important implications in the management of acute stress and anxiety, and potentially
chronic stress- and anxiety-related disease. An important component of the management of chronic 
non-communicable disease is the assessment and management of psychosocial stress, which is often
one of the most challenging aspects for the clinician. A reduction in stress will lead to improvement
in many diseases, especially cardiovascular disease. Patients with uncomplicated coronary artery
disease have decreased vagal drive to the heart 400;695 which contributes to an increased risk of
arrythmia 15. Increasing the vagal activation of the heart reduces myocardial ischemia, reperfusion-
induced arrythmias and the risk of sudden death after myocardial infarction 454;455. This study has 
shown an increase in vagal control of the heart following a short duration HRV biofeedback
intervention in healthy subjects. A similar effect of HRV biofeedback has also been shown in patients
with coronary artery disease 196. HRV biofeedback would therefore be a potentially valuable
intervention to include in the prevention and management of patients with cardiovascular disease, 
as well as other stress- and anxiety-related diseases.
Furthermore, this study showed that a single HRV biofeedback intervention resulted in improved
cognitive performance during stress. Cognitive function and HRV have been found to be directly
correlated 430;431 and both are negatively impacted by work related stress 130;144;212;336. HRV
biofeedback would therefore be a valuable intervention for people to use when working in stressful
environments.
HRV biofeedback is an inexpensive, time efficient and effective method of increasing HRV and 
increasing cardiac vagal modulation. It can be provided by hand-held portable devices such as the 
emWave2 or StressEraser, computer based interactive programs such as emWave desktop, Journey 
to the Wild Divine: Wisdom Quest or Relaxing Rhythms or with professional recording equipment 











at all times and so is available whenever needed such as before stressful situations or during 












A limitation of this study is that it may not be representative of the entire population. We elected to 
test only men in an attempt to limit heterogeneity as men and women have different responses to 
stress 48;637. Further research needs to be done to examine the benefit of HRV biofeedback for 
women. This sample also specifically evaluated men in senior managerial positions, and so may not 
be representative of all job descriptions. Furthermore, while the Stroop task has been shown to be 
an effective stressor  438, it may not be representative of stress induced outside the laboratory. 
Subjects received training with their respective devices without prior baseline physiological
recording. As a result of this, the respiratory rate in the BIO group during baseline testing in Rest 1
was lower than the COM group. It is most likely that this group difference was caused by the prior
training as the subjects in this study were randomised which should remove any group difference. In
addition, other studies have shown a tendency for subjects to breathe more slowly during rest
periods after HRV biofeedback despite instructions not to 458. Th re were no other group differences
during Rest 1. In hindsight, it would be better to take baseline physiological recordings prior to
training. Finally, it would also be advisable to record EMG of shoulder, neck and jaw musculature to











7.4 FUTURE RESEARCH 
This thesis was specifically interested in the acute effect of 10 minutes of biofeedback, as this is the 
period recommended for clinical use. The minimum recommended time per session is 5 minutes 
with a goal to accumulate a total of 20 minutes per day 635. While the benefits described in this 
thesis were achieved with only 10 minutes of intervention, greater benefits may be achieved with a 
longer duration of intervention as described by Sherlin et al 195, as well as with regular training, as 
often major improvements in relaxation states occur only after a few weeks of training 696. It would 
therefore be beneficial to investigate the effect of varying durations of a single episode of 
biofeedback to determine the optimal period of use. 
While there is benefit in the use of a single episode of biofeedback, there may be greater benefit
with regular training such as with the conventional HRV biofeedback training protocol as described 
by Lehrer. Long-term meditation is effective in reducing anxiety, improving attention and preventing
age-related reduction in grey matter volume, thus one could postulate that long term HRV
biofeedback could have similar effects resulting in reduced anxiety and increased performance. 
Furthermore, relaxation states show greater improvements after several weeks of intervention.
It would be beneficial to investigate the effect of HRV biofeedback on women, and on people of
different ages as well as different occupations. While we decided to use a single intervention and
comparative group design, as a crossover design may have confounded the interpretation in the
event of there being any carry over from the intervention; it would be useful to redesign the study to
include a crossover design effectively.
Finally, additional future research could include measurement of the biochemical markers of stress 
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Appendix A - Explanation of authorship for each publication 
1. Prinsloo GE, Rauch HGL, Lambert MI, Muench F, Noakes TD, Derman WE. The effect of short 
duration heart rate variability (HRV) biofeedback on cognitive performance during 
laboratory induced cognitive stress. Applied Cognitive Psychology 25: 792 – 801 (2011) 
 
2. Prinsloo GE, Derman WE, Lambert MI, Rauch HGL. The effect of a single session of short 
duration biofeedback-induced deep breathing on measures of heart rate variability during 
laboratory induced cognitive stress: a pilot study. Applied Psychophysiology and Biofeedback 
(in review, revisions requested) 
 
3. Prinsloo GE, Rauch HGL, Karpul D, Derman WE. The effect of a single session of short 
duration heart rate variability biofeedback on EEG: a pilot study. Applied Psychophysiology 
and Biofeedback (accepted for publication) 
 
4. Prinsloo GE, Derman WE, Lambert MI, Rauch HGL. The effect of a single episode of short 
duration heart rate variability biofeedback on measures of anxiety and relaxation states. 
International Journal of Stress Management (in review, revisions requested) 
For each study, I was involved in developing the study concept and design, collected and analysed 
the data, and completed the statistical analysis of the data. I interpreted the data and wrote the 
initial drafts of the papers as well as integrating all comments and completing the final drafts. 
Prof Derman was my primary supervisor. As such he was involved in developing the study concept 
and design, as well as providing a detailed critical revision of each of the manuscripts. 
Dr Rauch was my second supervisor. He was involved in developing the study design and concept. In 
addition, he provided guidance in the analysis and interpretation of data, especially the HRV and 
cognitive performance data, as well as providing a detailed critical revision of each of the 
manuscripts. 
Prof Lambert provided guidance in the statistical analysis of the cognitive performance, HRV and 
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Appendix C - Informed consent 
INFORMED CONSENT DECLARATION 
STUDY ON BIOFEEDBACK AND LIFESTYLE INDUCED STRESS  
As part of a research project that aims to understand the physiological benefits of a biofeedback 
(applied psychophysiology) technique in reducing your stress levels, you are invited to complete the 
attached questionnaires (describing your subjective perception of your levels of stress) and at a later 
stage to participate in the on-screen cognitive tests during which physiological changes in brain 
waves, respiration, skin conductance, muscle activity and heart rate will be measured. The 
anticipated time required to complete these tests is approximately 60 minutes.  Testing is not 
invasive and the methodology should not expose you to any risk. 
Participation in this study is completely voluntary, and you are free to choose not to complete the 
questionnaire, or opt out of the research at any stage. However you are kindly requested to 
participate as the study stands to enhance the understanding of the benefit of a biofeedback 
technique in reducing unhealthy levels of psychological stress. This psychological stress, if addressed, 
may result in a lowered risk of developing physiological disorders.   Your answers and individual 
identity will be kept strictly confidential. 
Date  ____________________________________________________________________ 
Name  ____________________________________________________________________ 
I hereby consent to participate in this research study with full knowledge and understanding of the 















Appendix D - Intake information 
Date of Birth:  Nationality: 
  Male         Female  Ethnicity: 
Highest level of education completed: 
 Did not complete high school 
 High school diploma or GED 
 Some college or associates degree 
 Bachelors degree 
 Masters, doctoral or other professional 
degree 
Marital status: 
 Single                            Live-in partner 
 Married                        Separated 
 Divorced                       Widowed 
 
Number of children: 
 0                   3                 6 or more 
 1                   4 
 2                   5 
How often do you exercise: 
 Less than once a month 
 Once or twice a month 
 Once a week 
 A few times a week 

















Appendix E - Questionnaires 
Appendix E.1 - Visual Analogue Scale 
1. How HELPFUL has the technique you used during the study to relax been in helping you relax? 
0 1 2 3 4 5 6 7 8 9 10 
    Not Helpful          Somewhat             Extremely 
            Helpful 
2. Did you become sleepy after 5 minutes of using your device? 
0 1 2 3 4 5 6 7 8 9 10 
      Not at all          Somewhat            Extremely 
3. Did you become sleepy after 10 minutes of using your device? 
0 1 2 3 4 5 6 7 8 9 10 
      Not at all          Somewhat            Extremely 
4. Did you become sleepy during the rest period (eyes closed) after using your device? 
0 1 2 3 4 5 6 7 8 9 10 














Appendix E.2 - Spielberger Trait Anxiety Inventory 
Patient Name __________________________    Date____________ 
Patient No. __________________________ 
 




A number of statements which people have used to describe themselves are given below.  Read each 
statement and then circle the appropriate answer to indicate how you generally feel.  There are no 
right or wrong answers.  Do not spend too much time on any one statement, but give the answer 




 Never Sometimes Often 
Almost 
 Always 
1. I feel pleasant 1 2 3 4 
2. I feel nervous and restless 1 2 3 4 
3. I feel satisfied with myself 1 2 3 4 
4. I wish I could be as happy as others seem 
to be  1 2 3 4 
5. I feel like a failure 1 2 3 4 
6. I feel rested 1 2 3 4 
7. I  am  “calm,  cool,  and  collected” 1 2 3 4 
8. I feel that difficulties are piling up so that I 
cannot overcome them 1 2 3 4 
9. I worry too much over something that 
really  doesn’t  matter 1 2 3 4 
10. I am happy 1 2 3 4 
11. I have disturbing thoughts 1 2 3 4 
12. I lack self-confidence 1 2 3 4 
13. I feel secure 1 2 3 4 
14. I make decisions easily  1 2 3 4 
15. I feel inadequate 1 2 3 4 
16. I am content 1 2 3 4 
17. Some unimportant thought runs through 
my mind and bothers me 1 2 3 4 
18. I take disappointments so keenly that I 
can’t  put  them  out  of  my  mind 1 2 3 4 
19. I am a steady person 1 2 3 4 
20. I get in a state of tension or turmoil as I 
think as I think over my recent concerns 
and interests 














Appendix E.3 - Spielberger State Anxiety Inventory 
Patient Name   _____________________    Date  ____________ 
Patient Nr.        _____________________ 
 





A number of statements which people have used to describe themselves are given below. Read each 
statement and then circle the appropriate number to the right of the statement to indicate how you 
feel right now, that is, at this moment. There are no right or wrong answers. Do not spend too much 
time on any statement, but give the answer which seems to describe your present feelings best. 
 
 
 Not at all Somewhat Moderately so Very much so 
1.   I feel calm. 1 2 3 4 
2.   I feel secure. 1 2 3 4 
3.   I am tense. 1 2 3 4 
4.   I feel strained. 1 2 3 4 
5.   I feel at ease. 1 2 3 4 
6.   I feel upset. 1 2 3 4 
7.   I am presently worrying over  
      possible misfortune. 1 2 3 4 
8.   I feel satisfied. 1 2 3 4 
9.   I feel frightened. 1 2 3 4 
10. I feel comfortable. 1 2 3 4 
11. I feel self-confident. 1 2 3 4 
12. I feel nervous. 1 2 3 4 
13. I am jittery. 1 2 3 4 
14. I feel indecisive. 1 2 3 4 
15. I am relaxed. 1 2 3 4 
16. I feel content. 1 2 3 4 
17. I am worried. 1 2 3 4 
18. I feel confused. 1 2 3 4 
19. I feel steady. 1 2 3 4 















Appendix E.4 - Smith Relaxation States Inventory 
HOW DO YOU FEEL RIGHT NOW? PLEASE CHECK ALL THE ITEMS USING THIS KEY. 
RIGHT NOW, I FEEL LIKE THIS 
 
①  ②  ③  ④  ⑤  ⑥ 
         Not at All             A Little       . . Moderately . .   A Lot          Maximum 
 
①   ②   ③   ④   ⑤   ⑥  1.   My mind is SILENT and calm (I am not thinking about anything). 
①   ②   ③   ④   ⑤   ⑥  2.   My muscles feel TIGHT and TENSE (clenched fist or jaws; furrowed brow). 
①   ②   ③   ④   ⑤   ⑥  3.   I feel AT PEACE. 
 
①   ②   ③   ④   ⑤   ⑥  4.   I feel DROWSY and SLEEPY. 
①   ②   ③   ④   ⑤   ⑥  5.   Things seem AMAZING, AWESOME and EXTRAORDINARY. 
①   ②   ③   ④   ⑤   ⑥  6.   Right now I recognize the wisdom of sometimes ACCEPTING things as they are. 
 
①   ②   ③   ④   ⑤   ⑥  7.   My muscles are SO RELAXED that they feel LIMP. 
①   ②   ③   ④   ⑤   ⑥  8.   I am HAPPY. 
①   ②   ③   ④   ⑤   ⑥  9.   I am WORRYING. 
 
①   ②   ③   ④   ⑤   ⑥  10. I feel AT EASE. 
①   ②   ③   ④   ⑤   ⑥  11. I feel DISTANT and FAR AWAY from my cares and concerns. 
①   ②   ③   ④   ⑤   ⑥  12. I feel ENERGIZED, CONFIDENT and STRENGTHENED. 
 
①   ②   ③   ④   ⑤   ⑥  13. I am DOZING OFF or NAPPING. 
①   ②   ③   ④   ⑤   ⑥  14. I feel THANKFUL. 
①   ②   ③   ④   ⑤   ⑥  15. I feel like I am fully and SIMPLY in the PRESENT, not distracted by past or future concerns. 
 
①   ②   ③   ④   ⑤   ⑥  16. Things seem TIMELESS, BOUNDLESS, or INFINITE. 
①   ②   ③   ④   ⑤   ⑥  17. I feel IRRITATED or ANGRY. 
①   ②   ③   ④   ⑤   ⑥  18. I feel JOYFUL. 
 
①   ②   ③   ④   ⑤   ⑥  19. I feel SAD, DEPRESSED, or BLUE. 
①   ②   ③   ④   ⑤   ⑥  20. I feel AWARE, FOCUSED, AND CLEAR. 
①   ②   ③   ④   ⑤   ⑥  21. My hands, arms, or legs are SO RELAXED that they feel WARM and HEAVY. 
 
①   ②   ③   ④   ⑤   ⑥  22. I feel INNOCENT and CHILDLIKE. 
①   ②   ③   ④   ⑤   ⑥  23. My BREATHING is NERVOUS and UNEVEN (Or shallow and hurried). 
①   ②   ③   ④   ⑤   ⑥  24. I feel LOVING. 
 
①   ②   ③   ④   ⑤   ⑥  25. Things seem FRESH and NEW, as if I am seeing them for the first time. 
①   ②   ③   ④   ⑤   ⑥  26. I feel INDIFFERENT and DETACHED from my cares and concerns. 
①   ②   ③   ④   ⑤   ⑥  27. I feel PRAYERFUL or REVERENT. 
 
①   ②   ③   ④   ⑤   ⑥  28. I feel PHYSICAL DISCOMFORT or PAIN (backaches, headaches, fatigue). 
①   ②   ③   ④   ⑤   ⑥  29. My mind is QUIET and STILL. 
①   ②   ③   ④   ⑤   ⑥  30. I feel ANXIOUS. 
 
①   ②   ③   ④   ⑤   ⑥  31. I sense the DEEP MYSTERY of things beyond my understanding. 
①   ②   ③   ④   ⑤   ⑥  32. I feel RESTED and REFRESHED. 
①   ②   ③   ④   ⑤   ⑥  33. I feel CAREFREE. 
 
①   ②   ③   ④   ⑤   ⑥  34. TROUBLESOME THOUGHTS are going through my mind. 
①   ②   ③   ④   ⑤   ⑥  35.My body is PHYSICALLY RELAXED. 
①   ②   ③   ④   ⑤   ⑥  36.  Presently  I  feel  there’s  no  need  to  try  to  change  things  that  simply  can’t  be  changed. 
 
①   ②   ③   ④   ⑤   ⑥  37. I feel fully focused and ABSORBED in what I am doing. 
①   ②   ③   ④   ⑤   ⑥  38. I feel OPTIMISTIC, HOPEFUL, or TRUSTING that I can rely on someone or something. 
 
Your age: _________________   Gender:  M      F 











Appendix F - Post test recording forms 
SE device history 
How many points did the participant get?     ________________ 
Exactly how long did they use the device for?     ________________ 
Did the participant have difficulty learning to use the device?       Yes            No
If yes, please describe here: 
__________________________________________________________________________________
___________________________________________________________________________ 
Control device history 
Exactly how long did they use the device for? ________________ 
How much Quality Time? ________________ 
Breathe Power? ________________ 
Average Wavelength ________________ 




Did the subject experience any adverse events?  Yes  No
Event: Specify Start date: 
Stop date: 
Time elapsed Severity: 




Relationship to treatment: 
1 Unrelated 
2 Probably not  
3 Possibly 
4 Probably 
5 Definitely 
